Funding News Preview

NIAID Funding News

Edition:

NIAID Funding News provides funding, policy, and other information to NIAID's extramural research community and Institute staff. Visit Stay Informed About Policy Changes and News for more opportunities to connect with us.

Changing Institutions? Steps to Take for a Grant to Go with You

If you are conducting human subjects research or research using vertebrate animals, you’ll need to begin the institutional review board or institutional animal care and use process, respectively, at the new institution.
Colorized scanning electron micrograph of red blood cell infected with malaria parasites (purple). The small bumps on the infected cell show how the parasite remodels its host cell by forming protrusions called 'knobs' on the surface, enabling it to avoid destruction and cause inflammation. Uninfected cells (orange) have smoother surfaces.

When a Modular Budget Is Right for You

Request a budget sufficient to make your proposed project successful; reviewers will not respond well when faced with a budget that is clearly inflated or insufficient for the proposed work.
Colorized scanning electron micrograph of Group A Streptococcus (Streptococcus pyogenes) bacteria (yellow) and a human neutrophil (blue).

Don’t Derail Your Application: Avoid These Electronic Submission Errors

Submitting your application well in advance of its receipt date will allow you ample time to validate the upload and correct any content-related upload errors.
Three scientists in a lab discussing research

Tabulating NIAID’s R01 and R21 Application and Award Counts for FY 2024

Each year, we share the number of R01-equivalent and R21 applications that NIAID received in the previous fiscal year as well as the number of grants NIAID awarded.
Scanning electron micrograph of methicillin-resistant Staphylococcus aureus (MRSA) bacteria (colorized green) interacting with a human neutrophil. The bacteria shown is strain MRSA252, a leading cause of hospital-associated infections in the U.S. and U.K. Image captured at NIAID's Rocky Mountain Laboratories (RML) in Hamilton, Montana.

Don’t Waste Your Time: Take an Extra Minute When Selecting NOFOs, Form Sets

We’ve now reached a stretch of time in which two form sets (i.e., FORMS-H and FORMS-I) and two versions of certain notices of funding opportunities (NOFOs) will be active simultaneously.
Labeled specimens for malaria and other vector research.

How to Use the World’s Largest Public Clinical Trials Registry as a Resource

While many researchers treat ClinicalTrials.gov only as a repository to submit required study information, it’s also worth thinking of it as an extensive online library.
A bi-lingual NIAID clinical trial coordinator provides free interpretation and translation services for patients with Limited English Proficiency.

Long COVID and the RECOVER-TLC Initiative

Long COVID’s broad and varied effects on diverse populations demand new clinical approaches and fewer restrictions to inclusion and access to achieve breakthrough results.
Colorized scanning electron micrograph of a cell (green) infected with SARS-CoV-2 virus particles, isolated from a patient sample.

NIAID Sets Interim Paylines, Financial Management Plan for FY 2025

Remember, paylines are funding cutoff points for investigator-initiated grant applications based on score during peer review. Notably, we’ve already set interim paylines for every relevant award type.
Workbench in NIAID intramural laboratory, with supplies and equipment.

Happenings from the September Meeting of NIAID’s Advisory Council

NIAID Director Dr. Jeanne Marrazzo shared remarks before NIAID's Advisory Council, as did Dr. Ted Piersen, Director of NIAID’s Vaccine Research Center.
Colorized transmission electron micrograph of an extracellular Nipah virus particle (red) on the periphery of an infected VERO E6 cell (blue). Nipah virus surface glycoproteins have been identified using a technique called “immunogold labeling,” in which gold particles (yellow) are bound to antibodies that recognize a specific viral antigen or epitope. Captured at the NIAID Research Facility in Fort Detrick, Maryland.

What Is the NIAID Advisory Council and What Does It Do?

NIAID's Advisory Council is comprised of both experts in health and science, contributing technical expertise and an understanding of the needs of research communities of academia and industry, and lay members, who impart a perspective of people and communities affected by diseases in the NIAID research mission.
Dr. Anthony Fauci presenting on AIDS during a visit to campus by Ronald Reagan in 1987.

Explore NIAID Topics for Small Business Innovation Research Contract Solicitation

The annual NIH solicitation serves as a vehicle for offerors to propose research projects on a multitude of scientific topics from across NIH. Proposals are due October 18, 2024.
Researcher measures volume of cell cultures for an experiment.

Small Business Research: Priority Funding Topics for 2025

NIH assembled a list of scientific priorities for small business awards that match the research interests of its institutes and centers, including NIAID.
Volunteer in trial of candidate universal flu vaccine BPL-1357 receives an intramuscular injection.

Check Whether Your Research Is a Good Fit for ARPA-H

The Advanced Research Projects Agency for Health (ARPA-H) aims to advance high-potential, high-impact biomedical and health research that cannot be readily accomplished through traditional research or commercial activity.
Dr. Renee Wegrzyn serves as the first director of the Advanced Research Projects Agency for Health (ARPA-H)

Looking to the Future at the June Meeting of NIAID’s Advisory Council

NIAID Director Dr. Jeanne Marrazzo shared remarks before NIAID's Advisory Council, as did Dr. Steven Holland, Director of NIAID's Division of Intramural Research.
Ariel view of NIH's Rocky Mountain Labs campus in Hamilton, Montana, looking west at Downing Mountain.

Explore Spending Estimates and Public Health Burden by Disease Category

NIAID often encourages researchers to use NIH RePORT tools—including Research, Condition, and Disease Categorization (RCDC)—to identify potential collaborators.
Malaria merozoites invading human red blood cells. Merozoites are covered in a fuzzy coating of surface proteins that are shed during invasion.

Bookmark NIH Webinars Page for Upcoming and Past Events on Funding Topics

For recently established policies, watching a webinar may prove an easier path to understanding NIH's new procedures than would reading policy announcements.
This photograph shows James Balow, Jr., M.S., biologist. He is inserting a GeneChip into the GeneChip fluidics station to analyze RNA from patient samples in order to identify genes that are differently expressed between patients with autoinflammatory diseases and controls.

Learn About NIAID Career Opportunities and How to Apply

While many jobs at NIAID require expertise specific to our area of science, you'll notice that many position titles and functional roles are often similar across NIH’s many institutes and centers.
Scientists from South Africa learn key aspects of the mRNA vaccine production process during a two-week visit to NIAID's Vaccine Research Center.

Explore the World of Research and Development Contract Solicitations

Contracts are government requirements for a product or service with specific goals, deliverables, and deadlines, and work done under a contract requires programmatic oversight by NIAID staff.
A variety of antiretroviral drugs used to treat HIV infection.

FORMS-I Transition: Setting Up Dominoes to Topple on January 25, 2025

NIH will transition to FORMS-I for application due dates on or after January 25, 2025, and also implement new policies and procedures that accompany the switch.
NIAID researcher reaching for cell cultures in a CO2 incubator.

Some Applications Have Deadlines for Actions Before the Due Date

NIAID staff can identify issues that may cause your application to be withdrawn, not fare well in peer review, or have lowered potential for an award. The earlier you contact us, the earlier we can provide advice that you can use to improve your application.
Two scientists observe ocular tissue samples under a laser scanning microscope

Know How to Demonstrate Scientific Progress in Annual Reports

Your program officer will assess the progress, delays, and planned next steps you describe and compare that to your budget request and justification for approval.
Scanning electron micrograph of Mycobacterium tuberculosis particles, the bacterium which causes TB

Examining NIAID’s R01 and R21 Application and Award Counts for FY 2023

We share the number of R01-equivalent and R21 applications that NIAID received in the previous fiscal year as well as the number of grants NIAID awarded. To add context, we present the data alongside the same figures for the preceding 4 years.
Bacteria in the gut. The human gut teems with bacteria and other microbes. They contribute to our health but also influence our susceptibility to certain diseases

New Leaders Take Center Stage at Advisory Council Meeting in January

This was the first meeting at which NIAID Director Dr. Jeanne Marrazzo shared remarks before NIAID's Advisory Council. It was also the first time that guest speaker Dr. Monica Bertagnolli, NIH Director, addressed our Council.
NIAID Director Dr. Jeanne Marrazzo addresses staff from the Institute’s Division of Extramural Activities

NIAID Uses Selective Pay, Bridge Awards to Complement Top-Scoring Applications

NIAID strives to always fund those applications that score best in peer review, but we also discern which applications outside the payline can help guard against scientific gaps emerging in our research portfolio.
Colorized image of Methicillin-resistant Staphylococcus aureus (MRSA) bacteria; from a scanning electron micrograph captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland.

Know Your Timeline to Award If All Goes According to Plan

Knowing when NIAID will begin funding your project is essential—it’s necessary for hiring support staff or arranging subcontracts or even timing a renewal application.
Researchers from the National Institutes of Health talk with a study participant at the NIH Clinical Center.

Don’t Be Fazed by Phased Awards

Submitted applications contain plans for two phases of research, including milestones that the applicant believes will justify continued support into the second phase.
Scanning electron micrograph of a human H9 T cell infected with HIV virus particles.

NIH or NIAID? Know the Difference

NIH is made up of 27 institutes and centers, each with a specific research agenda, often focusing on particular diseases or body systems.
Dr. Monica M. Bertagnolli became NIH Director on November 9, 2023

Promptly Determine Whether You’re Eligible to Apply

While a notice of special interest (NOSI) may stipulate eligibility criteria within its Purpose section, most NOSIs defer to the instructions listed in the identified notices of funding opportunities.
NIH Researches in a lab

Why Criterion Scores Don’t Add Up

The criterion scores reflect the views of the assigned reviewers while your overall impact score reflects the scores of all the panel members who voted.
NIAID researcher uses an electron microscope.

A Summary of Outcomes from Our September Advisory Council Meeting

NIAID Acting Director Dr. Hugh Auchincloss provided remarks on the Institute’s administrative, budget, and scientific news. He was followed by guest speaker Dr. Ted Pierson, Director of NIAID’s Vaccine Research Center, who discussed recent scientific advances and ongoing research priorities.
Theodore (Ted) C. Pierson, Ph.D., Director of the Dale and Betty Bumpers Vaccine Research Center at NIAID

Explore NIAID Topics for Small Business Innovation Research Contract Solicitation

NIH’s Small Business Education and Entrepreneurial Development program will host an HHS SBIR Contracts Solicitation webinar to discuss the opportunity on September 27, 2023, at 1 p.m. Eastern Time.
Creative artwork featuring colorized 3D print imagery of hepatitis B virus.

Inform the Center for Scientific Review of Your Assignment Preferences

By using the optional PHS Assignment Request Form, you can convey your preferences for which NIH institutes or centers and study sections are ideal to receive your next application.
Labeled specimens for malaria and other vector research.

How NIAID Sets a Payline—A Conservative Approach in Light of Uncertainty

We can increase a payline and then fund applications from earlier in the fiscal year that are now within the payline, but we cannot decrease a payline and pull back funding from awards already made.
Congressman Chris Van Hollen visits NIH

Explore Our Priority Topics for Small Business Research Projects

To accompany the annual small business parent notices of funding opportunities, NIH assembles a list of scientific priorities for small business awards of interest to its institutes and centers.
HIV Antibody Testing Kit

Grant Coming to an End? Avoid and Survive a Funding Gap

As long as you have accomplished enough to build a strong case for renewing your grant, apply early so you have time to revise and resubmit without risking an interruption in funding.
NIH experts care for a patient in Interventional Radiology

New Form to Disclose Foreign Relationships for Small Business Concerns

NIAID will require small business innovation research and small business technology transfer applicants to provide a “Required Disclosures of Foreign Affiliations or Relationships to Foreign Countries” form before issuing a grant award.
Colorized transmission electron micrograph of a single Nipah virus particle (center, colorized that has budded from the surface of an infected cell

Highlights from June’s Advisory Council Meeting

NIAID Acting Director Dr. Hugh Auchincloss discussed administrative, budget, and legislative updates, as well as recent scientific findings. Then Dr. Steven Holland, Director of NIAID’s Division of Intramural Research, described key research accomplishments at our intramural laboratories.
Dr. Steven M. Holland serves as director of NIAID's Division of Intramural Research

Successful Sample Applications Demonstrate Good Grantsmanship

To observe how other applicants approach grantsmanship, examine the text sections of the successful example applications—particularly the Specific Aims and Research Plans.
Students working in the lab beside one of their postdoc mentors.

Quiz Yourself on NIH Grant Funding Terminology

How familiar are you with NIAID’s application and grant terminology? Test your knowledge by taking our quiz and pay attention to the explanations for each answer.
A HISTEP student checks the eye color or her fruit flies during a genetics experiment.

There’s More to Biosafety and Biosecurity Than Select Agents

Review key terminology like dual use research of concern, enhanced potential pandemic pathogens, select agents, and recombinant or synthetic nucleic acid molecules.
Colorized scanning electron micrograph of Ebola virus particles both budding and attached to the surface of an infected VERO E6 cell

Address Just-in-Time Requests and Bars to Award Quickly

While most of the just-in-time information we request is routine, be aware that certain codes and comments in your summary statement can indicate a funding restriction or bar to award.
A photo of a woman and man sitting at a desk filling out paperwork.

Highlight Preliminary Data in Your Next Application

Focus on what reviewers would like to see in your application: enough information to convince them that your proposed project can be accomplished and is likely to have a high impact.
Researcher checks western/moisture blots to know if proteins bind to antibodies.

Generate Your Own Lists of Recently Funded Grants

You can create a list of recently funded NIAID grant awards to better assess the direction of preferences and priorities for NIAID peer reviewers and program staff.
Colorized scanning electron micrograph of Group A Streptococcus (Streptococcus pyogenes) bacteria and a human neutrophil.

Stay on Top of SAM Renewals and Organizational Registrations

NIAID cannot provide grant funds to organizations with an expired System for Award Management (SAM) registration; this includes competing and noncompeting awards.
3D print of hemagglutinin (HA), one of the proteins found on the surface of influenza virus that enables the virus to infect human cells

Reviewing NIAID’s Application and Award Counts for FY 2022

We share the number of R01-equivalent and R21 applications that NIAID received in the previous fiscal year (FY) as well as how many awards NIAID made in turn.
Respiratory syncytial virus (RSV) in cross-section landing on the surface of a human respiratory endothelial cell. Single stranded RNA (colorized purple) is shown wrapped around a nuclear protein core capped by large L proteins.

Appreciation for 2022 NIAID Peer Review and Committee Volunteers

On behalf of NIAID and our research community, we express our deepest gratitude to fiscal year 2022 review and advisory group volunteers for donating their precious time and effort.
VRC scientists working with a Biomek Nxp robot, which is used to set up and harvest cultures of HIV patients' B cells that are used in the discovery of novel HIV neutralizing antibodies.

Top Ten Things NIH RePORT and RePORTER Can Do for You

Use custom crafted queries to learn what active research projects represent the cutting edge of your field, find potential collaborators for future projects, and much more.
Bar graph shows number of active projects at each NIH institute and center.

Remember to Register, Review, and Update Records at ClinicalTrials.gov

Those conducting an NIH-funded clinical trial must promptly update study records, including updates in the recruitment status or study completion date(s), made no later than within 30 days of the occurrence.
Radiology Imaging at the NIH Clinical Center

R21 Grants Make for Slippery Stepping Stones

The exploratory/developmental grant (R21) activity code provides up to two years of funding support. Typically, direct costs for the entire project period are capped at $275,000.
materials on a lab bench

NIH and Tribal Nations—Commitment and Collaboration

Regular, meaningful engagement with Tribal partners helps NIH ensure American Indians and Alaska Natives are well-represented in research and benefit from its outcomes.
NIAID Director Dr. Anthony Fauci and THRO Director Dr. David Wilson

Extramural Research Overview for Fiscal Year 2020

NIH’s fiscal year 2020 appropriation totaled $41.6 billion. Of that total, NIH spent $30.8 billion to award 56,169 new and renewed extramural grants to 2,650 U.S. and international organizations.
Dr. Francis Collins, NIH Director

Highlights From January 2021 NIAID Advisory Council Meeting

In his remarks to NIAID’s Advisory Council, NIAID Director Dr. Anthony Fauci shared key staff transitions, legislative updates, and COVID-19 news.
Dr. Fauci at Vaccine Kick-Off Event

Writing a Winning Application—Write To Excite

Create a winning application by keeping your NIH peer reviewers in mind as you anticipate questions about your project's significance and innovation.
dissecting microscope

Writing a Winning Application—Consider the Review Committee

Match your research project to a review group with appropriate expertise and create an application that appeals to the reviewers and catches their interest by proposing concepts and preliminary data they would regard as innovative.
researcher uses a dissecting microscope

Taking a New Approach to Our Research Training Portfolio

NIAID is committed to improving the availability and effectiveness of our training, fellowship, and career development awards, to include increased support for certain research training activity codes.

Adjustments to NIH Policy for Subawards and Implementation

This summer, NIH announced planned changes to its policy on subawards—arrangements in which a grant recipient has another organization perform grant-supported research activities as part of the federal award.

Opportunities and Resources

Study How HIV-Driven Changes to Immunometabolism Impact Immune Response to TB and HBV

We aim to increase understanding of these mechanisms in order to identify candidate markers of disease progression as well as potential targets for immune-modulatory treatment to decrease TB and HBV risks in people living with HIV. 

Apply to Advance Asthma and Allergic Diseases Translational Research

The cooperative research program will support centers that integrate clinical and translational research to conduct studies on mechanisms underlying the onset and progression of asthma and allergic diseases.

Develop Novel Research Approaches to Target Cell Surface HIV Envelope for Cell Elimination

This notice of funding opportunity supports basic research on HIV-1 Env biology, and/or translational research that develops or optimizes biologics.

Help Develop Long-Acting and Simplified HIV Treatments

NIAID will support the development of safe and effective long-acting/sustained release technologies to help prevent and treat HIV and related co-infections such as tuberculosis, hepatitis B, and hepatitis C.

Collaborate to Defeat Antibiotic-Resistant Bacterial Infections

NIAID will support multidisciplinary, collaborative research programs focused on discovery to early development research to inform new approaches to prevent, diagnose, and treat antibiotic-resistant bacterial infections.

Combat Antibiotic Resistance Through Phage Therapy Research

Propose a multidisciplinary research group that will implement phage therapeutic research by focusing on preclinical development and study pharmacokinetics and pharmacodynamics.

Develop Therapeutic Treatments for Genital Herpes Through Novel Approaches

NIAID seeks to capitalize on the robust herpes simplex virus basic research field and to encourage more researchers to advance products into the development pipeline.

Fighting Fungal Pathogens Through Discovery of Novel Therapeutics

We seek milestone-driven, early-stage translational research focused on drug discovery and development of novel therapeutics against select fungal pathogens including Candida species that remain a clinical challenge.

Advance Research Strategies to Eliminate HIV Proteins

Propose to discover and develop novel therapeutics directed at intracellular HIV targets and eliminate viral proteins by mechanisms like protein degradation, targeting of viral RNA through inhibiting RNA processing as well as degradation.

NIH Invites Applicants to Support a Pediatric HIV Cohort Study

This opportunity is designed to support cohorts of the Pediatric HIV/AIDS Cohort Study—a streamlined and agile grant program that addresses developmental and clinical issues that affect individuals with HIV.

NIH Calls for Implementation Science to Help End HIV in the United States

Projects should include meaningful engagement with implementing partners such as public health departments, healthcare organizations, and other service providers, as well as community members and people with lived experience.

Understand the Critical Drivers of Tuberculosis Transmission

Greater knowledge of the interactions and factors driving tuberculosis transmission would allow efficacious approaches for preventing transmission to be developed or improved and adapted for broad scale-up.

Help Strengthen the Pipeline of Antiviral Drugs for the Next Pandemic

This opportunity encourages discovery and development of small molecule compounds with activity against viral targets that could be administered orally as monotherapy or in combination with other drugs to treat infections caused by viruses of pandemic potential.

Call for Effective Data Reuse in Health Research

Demonstrate innovative approaches to data reuse, explore strategies for leveraging data across data resources, and identify methods to ensure effective integration of data obtained through secondary analysis.

New Initiative Shines a Spotlight on Women’s Health in HIV Research Continuum

NIAID is interested in supporting research programs that focus on HIV and other health outcomes in women to inform and enable more targeted and effective HIV prevention and treatment.

Pursue Research on Engineering Durable HIV Vaccine Responses

Through a new initiative, we aim to fund hypothesis-driven research to investigate and improve the durability of immune responses to candidate vaccines for HIV prevention.

Examine Human Leukocyte Antigen, Killer-cell Immunoglobulin-like Receptor Genomics

Apply to investigate the relationship between genetic variation in human leukocyte antigen and killer-cell immunoglobulin-like receptor region genomics and immune-mediated diseases.

Examine Impact of Hormone Regimens on Treatment and Prevention for HIV and Co-Infections

NIAID will support studies that examine the impact of hormone therapy and antiretroviral drugs on treatment and prevention methods of HIV and other sexually transmitted infections.

Apply to Develop Clinical Research Platforms to Tailor HIV Curative Strategies

Build a practical clinical research platform for rapidly and efficiently profiling participants’ intact, rebound-competent HIV reservoirs and their immunologic profiles.

Opportunity to Develop Pediatric Research Models for Chemical Injury

NIAID will support basic research to elucidate mechanistic differences in susceptibility to chemicals of concern between pediatric and adult populations as well as applied research towards the discovery and early development of pediatric-safe medical countermeasures.

Support and Build Interdisciplinary Research Careers in Women’s Health

Each award’s principal investigator should be an established investigator capable of providing administrative and scientific leadership to the development and implementation of a career development program.

Climate Change and Health Initiative Is Focus of New NOSI

The notice of special interest (NOSI) encourages grant applications from Small Business Concerns to develop commercializable tools, resources, and approaches to capture the effects of climate change and the associated impacts of extreme weather events on human health.

Improve Understanding of Mechanisms, Biomarkers of Trained Immunity

Apply for research support to study basic mechanisms and biomarkers of trained immunity (i.e., innate immune memory), plus the functional implications of trained immunity.

Take Note of Reissued Investigator-Initiated Clinical Trial NOFOs

The NIAID Clinical Trial Implementation Cooperative Agreement notice of funding opportunity (NOFO) is designed for high-risk trials. The NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement NOFO allows small business concerns to proposed investigator-initiated clinical trials.

New Bat Immunology Network Will Support Immune Mechanism Studies

NIAID aims to better understand the mechanisms by which bats regulate immune responses to clear infection and prevent or resolve excessive inflammation.

Develop 3D Organotypic Culture Models for Transplantation Immunology Research

3D organotypic culture models offer improved modeling of tissue architecture, cell-cell interactions, and other microenvironmental aspects of tissues and organ systems.

Develop Anti-Infective Strategies Against Viral, Bacterial, Parasitic, and Fungal Pathogens

NIAID seeks research projects to discover and develop compounds that promote targeted protein degradation of viral, bacterial, parasitic, or fungal pathogen components, as well as non-protein targets.

Conduct Multidisciplinary Research on Hepatitis B Cure in Persons Living with HIV and HBV

Research the impact of host and viral heterogeneity on pathogenesis of disease, viral persistence, and immunopathology of Hepatitis B virus (HBV) and inform cure strategies for HBV in people living with HIV.

NIH Seeks Implementation Research Projects to Help End HIV

Apply if you can expand or improve engagement and re-engagement in HIV prevention, testing, treatment, and care services, or improve strategies to deliver integrated HIV prevention, treatment, and care services to address co-morbidities and co-infections.

Expanded Opportunity to Conduct Basic Research on HIV Cure Strategies

NIAID will support basic research into novel mechanisms that contribute to intervention-mediated viral control and reductions in reservoir size as well as experimental, innovative targeted intervention activities.

Create Research Tools for Difficult-to-Culture Eukaryotic Pathogens

Help address a deficiency in genetic tools and culture conditions that has blocked the development of medical countermeasures for select human eukaryotic pathogens.

Support for HIV-Associated Product Development Strategy Planning

Our new planning grant program will accelerate next-generation treatments for HIV and HIV-associated comorbidities, co-infections, and complications, and preventative strategies for HIV.

Support to Study Immune Evasion in Tickborne Diseases

Understanding immune evasion by pathogens may be a critical factor in improving the design or utilization of prevention strategies, diagnostics, and treatments for tickborne diseases.

Apply to Support a Chemical Exposure Resource and Coordination Core

NIAID aims to support multidisciplinary Chemical Countermeasures Research Program-funded investigators through the development of infrastructure and exposure protocols for selected chemicals of concern.

Advance Research to Fight Congenital and Adult Acquired Syphilis Infections

Help us advance and improve congenital and adult acquired syphilis research. We encourage translational diagnostic development research including the collection and use of clinical samples.

Develop Vaccine Research Approaches Against Enteric Viruses

NIAID will fund studies to develop vaccine candidates against enteric viruses that cause gastroenteritis in infants and young children, immune-compromised and -suppressed people, and elderly people.

R01-Equivalent Funding for Postdocs and Newly Independent Investigators

Through this initiative, our aim is to facilitate the movement of exceptional postdoctoral fellows into independent positions within an accelerated timeframe, and further support them as talented, newly independent faculty.

New Opportunity to Explore Sex Differences in Radiation Research

Have you observed radiation-associated sex differences in your early-stage research to advance animal models, medical countermeasure development, safety, or biomarker science?

Initiative Takes International Approach to Infectious Diseases

Apply if you are an international investigator in a resource-constrained country and can propose high-priority, regionally relevant infectious diseases research.

Propose Research on Mechanisms of Viral Invasion of Central Nervous System

Apply if you can conduct research focused on less-studied emerging and re-emerging neurotropic viruses for which there are currently no approved vaccines or therapeutics.

Funding to Characterize Post-Tuberculosis Lung Disease in HIV-Infected Individuals

Conduct epidemiological and observational research projects on the long-term cardiopulmonary sequelae following treatment for tuberculosis in persons living with and without HIV infection.

ReVAMPP Network—NIAID Plans $100 Million for Pandemic Preparedness

A set of new initiatives will create research centers in support of the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network.

New Program Will Boost Aspiring Clinician Scientists

Through its new Medical Scientist Partnership Program, NIH will sponsor predoctoral students pursuing both a clinical doctoral degree and a biomedical research doctoral degree.

Develop Vaccine Candidates for Sexually Transmitted Infections (STIs)

This initiative will focus on advanced vaccine development for STI pathogens that have limited candidates in the product development pipeline: Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum.

New Initiative Focuses on Food Allergy Research

NIAID established the clinical trial network Consortium for Food Allergy Research to address concerns about the increasing incidence of food allergy and paucity of treatment options.

Four Research Areas Comprise NIAID’s 2023 Omnibus Contract Solicitation

Successful offerors will help advance the research and development of promising candidate vaccines, therapeutics, and diagnostics for biodefense, emerging infectious diseases, and pandemic preparedness.

Contract Opportunity Renews NIAID Adjuvant Discovery Program

NIAID seeks to renew the Adjuvant Discovery Program, which supports the identification and characterization of novel, effective, and safe vaccine adjuvants.

Another Opportunity for NIAID New Innovators Award Approaches

Our aim is to facilitate the movement of exceptional postdoctoral fellows into independent positions within an accelerated timeframe, and further support them as talented, newly independent faculty.

Provide Quality Assurance for Virologic Assays

The program provides comprehensive quality assessment evaluations for virologic assays for HIV and other viral pathogens performed on samples collected from participants enrolled in NIAID-sponsored and collaborative multisite clinical studies. 

Study the Mechanisms of Combination Adjuvants in Vaccines

Propose research studies to explore the mechanisms of action of combination adjuvants that have already been shown individually to be effective in enhancing or modulating immune responses when compared with an antigen alone.

Characterize Role of Defective Proviruses in HIV Persistence

This notice of funding opportunity seeks research to characterize the role of defective HIV in blood and tissue sites in people living with HIV on antiretroviral therapy.

Contribute to Development of a Universal Influenza Vaccine

NIAID aims to foster new and innovative scientific endeavors related to universal influenza vaccine research that advance the major research areas defined in our Strategic Plan for the Development of a Universal Influenza Vaccine.

Establishing Preclinical Animal Models to Study Post-TB Lung Disease Development

While most of our understanding of Post-TB Lung Disease (PTLD) comes from long-term human cohorts, using animal models for PTLD development could help address difficult mechanistic questions when relying solely on human studies.

Investigate Understudied Proteins Associated with Rare Diseases

Gather preliminary data around the role of understudied proteins associated with rare diseases and characterize new targets for treatment of human disease among them.

NIAID Calls for Development of Alternative Human Models to Address Radiation-Induced Injuries

Find support for early- to mid-stage research and development of extracorporeal systems that mimic human responses and test appropriate medical countermeasures to treat civilian populations.

NIH Kicks Off Next Phase of U.S.-South Africa Program for Collaborative Biomedical Research

Submit an application to help foster, stimulate, and expand research on HIV/AIDS, HIV/AIDS comorbidities and co-infections, HIV/AIDS-associated implementation science, and HIV/AIDS-associated data science.

Supporting Health-Related Research Endeavors Among AI/AN Tribal Entities

This initiative funds federally recognized American Indian/Alaska Native (AI/AN) tribes, tribal colleges or universities, tribal health programs, or tribal organizations to support health-related research, research career enhancement, and research infrastructure enhancement activities.

Propose a Human Tissue and Organ Research Resource Program

NIAID will help support and advance a human organ and tissue resource to provide a wide variety of human tissues and organs, diseased and normal, young and aged, to investigators for laboratory studies depending on research needs.

Accelerate Novel Medical Countermeasures Effective Against Radiation Injuries

Projects will focus on novel ideas in radiation research, specifically medical countermeasures, biodosimetry, or animal model development to diagnose, mitigate, or treat injuries sustained during a radiation mass casualty incident. 

Study Immune Responses Triggered by Bioactive Components in Arthropod Saliva

Apply for funding to research immunologic events in vertebrate hosts that occur at the bite site (skin) and systemically during and after feeding by hematophagous and ectoparasitic arthropods.

Focus of New Opportunity: Mechanisms of Inducing HIV Immunity in Early Life

Investigate and advance the mechanistic understanding on how immune ontogeny and functionality in early life could be harnessed in the context of HIV vaccines and broadly neutralizing antibodies to protect against acquisition of HIV infection. 

Explore Mechanisms of Adverse Health Effects After Toxic Chemical Exposure

Conduct fundamental research to characterize the acute or long-term pathophysiological effects of toxic chemical exposure on the pulmonary, ocular, or neurological system.

Apply to Develop Global Infectious Disease Research Training Programs

This initiative aims to strengthen the research capacity of institutions in low- and middle-income countries to investigate methods for preventing, treating, and controlling infectious diseases that pose significant health risks.

Advance HIV Service Delivery Through Pharmacies and Pharmacists

Apply if you can conduct research to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in U.S. or global settings.

Develop Tools to Tackle Antibiotic-Resistant Gram-Negative Bacteria

This opportunity will support milestone-driven projects focused on developing novel predictive models, assays, tools, or platforms aimed at gaining a better understanding of the rules and compound properties that govern the penetration and efflux of drug-like small molecules into Gram-negative bacterial pathogens.

Join the Immunobiology of Xenotransplantation Cooperative Research Program

The Immunobiology of Xenotransplantation Cooperative Research Program supports research in preclinical nonhuman primate and human decedent models of porcine pancreatic islet, kidney, heart, lung, or liver xenotransplantation.

Explore Opportunities to Join Emerging Infectious Diseases Network

The Centers for Research in Emerging Infectious Diseases Network works to expand knowledge of re-emerging and emerging infectious diseases around the globe.

Keep Diverse Perspectives and Safety Plans in Mind When Applying for Conference Grants

Through this notice of funding opportunity, you can receive funding to pay for national, international, and regional conferences, meetings, and workshops. Keep in mind, this award is not meant to fund an individual’s travel to a conference; rather, the funds are provided to the conference organizer.

Apply for Support to Lead Computational Modeling Efforts

A new Center will perform activities to coordinate the modeling community through coordinating cores and conduct research projects to advance modeling across and between scales of infectious and immune-mediated disease.

NIAID Seeks Contractors to Provide Vaccine Manufacturing Services

The solicitation’s purpose is to support manufacturing of material to advance preclinical, nonclinical, and Phase I/II clinical studies (e.g., vaccines, other biologics, vaccine components, and reagents).

Conduct Radiation Biodosimetry Research for Use in Public Health Emergencies

A new opportunity supports radiation research at all stages of development for identifying biomarkers of injury and developing assays or devices for the purpose of triage, including assessing absorbed dose or predicting health outcomes of acute or delayed injuries.

Funding to Engage in Bioethical Research and Capacity Building Efforts

Focus on ethical, legal, and social implications (ELSI) research relevant to NIAID’s scientific mission: HIV/AIDS or its comorbidities; infectious diseases; organ transplantation; and ELSI of clinical trials and implementation science.

Apply to Research Initiative to Enhance Vaccine and Antibiotic Allergy Research

Conduct an innovative project to study the mechanisms and management of vaccine or antibiotic drug allergy, including research on allergic responses to anti-viral, anti-fungal, and anti-parasitic drugs.

Participate in Research Education Program to Support a Diverse Workforce

Through courses for skills development and mentoring activities, NIAID strives to support current and future research investigators from diverse backgrounds.

Study Long-Acting Drug Delivery Systems for ART Optimization in Children with HIV-1

This initiative will stimulate the optimization and evaluation of long-acting drug delivery systems formulations in suitable preclinical animal models at an earlier age of adult drug development.

Another Chance to Participate in HIV Vaccine Research and Design Program

Request support for multi-component, multidisciplinary projects that address scientific questions relevant to AIDS prophylactic vaccine discovery research.

Help NIH Advance Rheumatic Heart Disease Research

Help discover innovative methods and strategies to support the eradication of Rheumatic Heart Disease, which remains endemic in low- and middle-income countries and low-resource settings.

Apply to Create a Diagnostic Center of Excellence for the Undiagnosed Diseases Network

Successful applicants will demonstrate that they have the appropriate expertise, resources, and infrastructure needed to conduct advanced diagnostic evaluations at their site.

NIH Reissues Parent Fellowship Opportunities; New AIDS-Related F31 Application Deadline

Fellowship grants provide stipends, tuition and fees, and an institutional allowance. Funding levels will vary depending on the candidate’s experience and proposed Research Plan.

Propose Studies as Part of SUNBEAM Birth Cohort Study

Use study samples to gain a deeper understanding of mechanisms contributing to the development of allergic diseases, disease endotypes, and molecular targets for disease prevention.

Small Businesses—Facilitate Transition to Commercialization Stage

The notice of funding opportunity helps Phase II and Phase IIB projects' progression to the commercialization stage by providing additional support for technical assistance and later stage research and development.

Use a Research Supplement to Help Yourself and Someone Else

To apply, you must propose a research project integral to the approved, ongoing research of the parent award, with the potential to contribute significantly to the career development of the candidate.

NIAID Seeks HIV Cure-Related Research in Diverse Cohorts

Propose basic, preclinical, or clinical research studies using existing human samples to analyze and compare HIV reservoir establishment, dynamics, persistence, and post-treatment control among different HIV subtypes and in diverse cohorts of people living with HIV.

Are You a Clinician? Then You Should Know About R34s

The clinical trial planning grant (R34) supports planning, design, and preparation of the documentation necessary to implement an investigator-initiated clinical trial.

Apply for Funds to Study Immune Mechanisms at the Maternal-Fetal Interface

Improve our understanding of the roles and interactions of immune cells at the maternal-fetal interface that support pregnancy and enable optimal placental development and function.

Analyze Mechanistic Studies of Early Events in TB/HIV Infection

Conduct mechanistic studies of early-stage Mtb infection in the airway and lungs with and without HIV to identify interventional targets for vaccine and host-directed therapies.

Apply for Funds to Develop Innovative, High-Impact HIV Vaccine Approaches

The initiative supports early discovery of novel exploratory vaccine strategies to prevent HIV infection, as well as worthy basic vaccine discovery research that has not yet been fully exploited.

Reissued Funding Opportunity Centers on ME/CFS

Collaborative research centers will help provide the foundation and infrastructure to complete basic, translational, and mechanistic clinical trials focused on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

We Want You to Develop Animal Models for Hepatitis B and C

In your application, describe plans to develop either small animal models or surrogate virus-host systems for hepatitis B virus or hepatitis C virus research.

Find Funding for Translational Research in Maternal and Pediatric Therapeutics

NIAID will support research to improve safe and effective precision therapeutics for pregnant and lactating persons, fetuses, neonates, and children, including those with disabilities.

Two Opportunities to Join NIH’s Centers for AIDS Research Network

The Centers for AIDS Research program fosters synergy and research coordination, supports emerging research opportunities, and promotes resource sharing among institutions that receive significant HIV/AIDS funding from NIH.

Investigate Vaccine Formulations with HIV Immunogens and Adjuvants

NIAID is soliciting contract proposals from offerors capable of providing a broad range of services to investigate vaccine formulations with HIV immunogens and adjuvants.

Administrative Supplement Supports Research Testing on Gender Measurement

The health conditions of interest to NIAID impact the health of sexual minority and majority populations, and the Institute endorses meaningful sexual orientation and gender identity measurement in research, clinical care, and administrative settings.

Check Out Career Development Opportunity for Early-Career Physician-Scientists

The Physician-Scientist Pathway to Independence Award is designed to increase and maintain the field of new and talented physician-scientists by supporting mentored research training and an independent research period.

New Solicitation Focuses on Development of Cellular Immunology Core

NIAID seeks a partner to operate the Cellular Immunology Core Laboratory, which will conduct, analyze, develop, optimize, and validate cellular immunologic assays for multiple pathogens, to be performed on fresh and frozen preclinical samples.

Participate in the Cooperative Centers on Human Immunology Program

Conduct research on human immune system regulation and function to discover and characterize new principles of human immunology for preventing and treating infectious diseases, immune-mediated pathogenesis, and immune-mediated diseases.

Contract Solicitation Focuses on Enhancing MTB Lab Testing in NIAID Clinical Trials

The Mycobacterium tuberculosis (MTB) Quality Assessment Program will serve NIAID-sponsored and collaborating clinical trial networks and cohorts as well as individual grantees conducting research in and outside the United States.

Trio of COVID-Related Opportunities Cover Variety of Research Priorities

Three initiatives cover distinct topics: pathobiological mechanisms of post-acute sequelae, pediatric COVID-19 and respiratory viral co-infection, and vaccine hesitancy among health disparities populations.

Apply To Conduct Basic Science Research on Bunyavirales Pathogens

NIAID aims to develop a range of approaches for studying bunyaviruses using both established and novel technologies, prioritizing vector competence, virology and pathogenesis, and human innate and adaptive responses to infection.

Take Part in Continuing a Long-Running HIV Cohort Study

The cohort study platform will collect and make publicly available high-quality risk factor, viral suppression, and other outcome data on HIV and associated comorbidities in middle-aged and older adults in the United States.

Develop Novel Therapeutics to Treat Botulinum Neurotoxin Intoxication

The initiative promotes discovery of novel, improved candidates for treating Botulinum Neurotoxin (BoNT) toxicity, as well as platforms for the intraneuronal delivery of antitoxins to reverse BoNT intoxication.

Leverage Microbial Exposure to Improve Mouse Models of Human Immunity

Advance our understanding of the impact of a host’s microbial experience on the development and function of host immunity and provide the data necessary to encourage broader use of the mouse models in immunologic and microbiologic research.

Explore Mechanisms of Adverse Health Effects on the Nervous System After Toxic Chemical Exposure

Propose research on the fundamental mechanisms of toxicity of highly toxic Chemicals of Concern but also on potential new targets to inform the development of medical countermeasures that would be effective during and after civilian mass exposure situations. 

Conduct Translational Exploratory Research on Chemical Countermeasures

Research civilian chemical medical countermeasures and novel treatment strategies to combat serious morbidity and mortality resulting from high consequence public health chemical emergencies.

Administrative Supplements for Women’s Health Research in U3 Populations

Active grant awardees can receive support for in-scope research to reduce health inequalities among women who are understudied, underrepresented, or underreported in biomedical research.

Enhance Diversity in SBIR/STTR Research Through Administrative Supplements

Recruit, mentor, and support students, postdoctoral scholars, and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research.

Organize Meetings for the Chemical Countermeasures Research Program

Apply to organize a series of annual in-person scientific meetings, conferences, symposia, and workshops to advance innovations in therapeutic and chemical toxicology research.

Novel Research Projects to Build Understanding of Congenital Syphilis

Request support for basic and exploratory research projects that leverage recent scientific development to advance our understanding of Treponema pallidum bacterial pathogenesis.

Use Collaborative Cross Mouse Model for Immunoregulatory and Infectious Disease Research

Develop and validate use of Collaborative Cross mouse models to reproduce the impact of host genetic variations on human immune system responses, and screen and evaluate mouse lines for use in specific studies and disease models.

Pursue Epigenetic Treatment Strategies Against HBV in HBV/HIV Co-Infection

Apply for funding to conduct innovative basic, translational, and clinical research to identify and address epigenetic treatment strategies for achieving hepatitis B virus (HBV) cure in people living with HIV.

Call for Applications for the Lasker Clinical Research Scholars Program

The Lasker Scholars program supports candidates in two phases: an initial phase within the NIH Intramural Research Program and a subsequent phase with extramural grant funding.

Help End the HIV Epidemic Through Resource-Related Research Projects

NIAID will establish a Coordination, Consultation, and Data Management Center and multiple Regional Consultation Hubs to support NIH's Ending the HIV Epidemic in the U.S. Initiative research portfolio.

Request Funding to Explore Controlled Release of HIV Vaccines

Conduct product-focused research to advance controlled-release vaccine strategies shown to improve immune responses for HIV prevention, treatment, and cure, and also to develop simplified or single-shot vaccination formulations.

Request Support to Study Inborn Errors of Immunity

Research the causes and mechanisms of inborn errors of immunity, enable early detection and molecular diagnosis, and support strategies to treat and cure these disorders.

Small Businesses—Request Funding for Non-Viral Technologies to Deliver RNA-Based Therapeutics

Apply to test and evaluate non-viral technologies capable of delivering RNA-based therapeutics into disease-relevant cells and tissues in vivo through a new notice of special interest.

NIAID Seeks Dosimetry Verification Services to Harmonize Radiation Research Projects

Our Radiation and Nuclear Countermeasures Program seeks a contractor who can provide services and capabilities to maintain and expand a centralized dosimetry harmonization effort.

Big Opportunity to Join Centers for Excellence in Translational Research

NIAID seeks applications from single institutions or consortia of institutions ready to generate, validate, and advance medical countermeasures against a select list of bacteria or fungi with known or emerging resistance to current therapies.

Don’t Overlook an Opportunity for Intramural Collaboration

NIAID invites applications from actively-funded grant recipients to travel to NIAID laboratories for a short duration to perform research in partnership with a host intramural research investigator.

Engineer Innovative Products to Kill HIV-Infected Cells

NIAID will fund research on late-stage engineering and preclinical development of innovative biological products that safely and specifically engage the immune system to kill HIV-infected cells.

New Opportunity to Develop Models of Autoimmune Diabetes

Apply to study early islet dysfunction, autoimmunity initiation, and other metabolic perturbations present during the early stages of type 1 diabetes disease for which there are still few clinical interventions.

An Initiative to Support Senior Administrators from Low- or Middle-Income Countries

Our goal is to improve oversight of NIAID grant awards and compliance with NIH funding policies and federal research funding requirements for NIAID-supported foreign institutions.

Focus of Funding Opportunity—Interventions to Improve Health in Native American Populations

Design interventions with consideration for sustainability within the communities where they are tested, and with the flexibility to be readily adapted, disseminated, and scaled up to other communities where culturally appropriate.

Funding Opportunity on Smart Health, AI, and Advanced Data Science

The Smart Health program supports high-risk, high-reward advances in computer and information science, engineering, mathematics, statistics, behavioral, and cognitive research to address pressing questions in the biomedical and public health communities.

Identify Novel Research Targets to HEAL Opioid Use Disorders

Develop new medications by identifying novel research targets and lead molecules to develop therapeutic approaches that will be effective at various stages along the trajectory of opioid use disorders.

STRONG Opportunity for Resource-Limited Institutions to Build Research Capacity

STRONG program funds can help you analyze your institution’s research capacity needs and strengths, then create an action plan to meet those needs and leverage areas of strength.

Propose Research on Mucosal Immunity Against Enteric Eukaryotic Pathogens

Aim to build on recent breakthroughs in biology of mucosal systems, biology and immunology of mucosal infection, and microbiome research.

Develop Data Science Software in Infectious and Immune-Mediated Diseases Research

Apply for funding to develop data science software that improves acquisition, management, analysis, visualization, and dissemination for data science research on infectious and immune-mediated diseases.

Find Funding to Discover Novel B Cell Epitopes

This program supports high throughput discovery and validation of novel B cell epitopes associated with infectious pathogens or vaccines against them, autoimmune diseases, allergens, or human leukocyte antigen epitopes associated with cell, organ, or tissue transplant rejection or tolerance.

Opportunity to Create a Bioinformatics Research Center

Each center will create and provide access to interactive knowlegebases, innovative tools and software, and leading-edge expertise in bioinformatics.

Research Synthetic Nucleic Acid Platforms to Fight HIV

Propose research to apply newly developed immunological tools and expand understanding of the immune response to vaccination at the molecular level.

Resources for Sites Providing Diagnostic Services for Patients with Undiagnosed Diseases

Demonstrate that your clinical site has a track record of diagnosing rare and difficult-to-diagnose disorders, with appropriate expertise as well as the infrastructure and resources needed to conduct clinical evaluation and DNA sequencing of participants enrolled at your site.

Scrutinize Molecular Mechanisms Amid Suppressive Antiretroviral Therapy

NIAID aims to spur new approaches that target HIV transcription to shut down the expression of HIV RNA, proteins, and virus that occurs despite interruption of the viral life cycle by antiretroviral therapy.

Administrative Supplements for Climate Health, Software Tools, Data Readiness

NIH published three notices of special interest that each offer administrative supplements for ongoing research projects to further explore priority topics: climate health, software tools, and data readiness.

NIAID Solicitation Seeks Preclinical Animal, Animal-Replacement Models

Can your organization develop, refine, and use animal and animal replacement models to assess candidate therapeutics, vaccines, and diagnostics targeted at infectious diseases and generate difficult-to-source reagents requiring an in vivo model?

NIAID-Supported HIV Vaccine Trials Network Has New Specimens Available

The HIV Vaccine Trials Network (HVTN) invites outside investigators to apply to use Imbokodo/HVTN 705 participant specimens or study data to conduct independent scientific research. Respond by April 4, 2023.

Gain Support for Mentored Career Development Using Nonhuman Primate Models

By facilitating access to experienced mentors, relevant facilities, and protected time for training centered on nonhuman primate models, these awards will help early-career scientists address key issues in clinically relevant research areas.

Reissued Supplements Provide Support for Early-Career Continuity

The funds may be used to pay for computational services, supplies, equipment, and supported effort of additional scientific staff to sustain the research project while an investigator gives priority to a critical life event.

Administrative Supplements for Women’s Health Research in U3 Populations

The Notice of Special Interest encourages rigorous interdisciplinary research on the complex intersection of women’s health, sex and gender, and social determinants of health.

Two Research Areas Comprise NIAID’s 2026 Omnibus Contract Solicitation

NIAID's Division of Microbiology and Infectious Diseases will use this Broad Agency Announcement to advance the research and development of promising candidate therapeutics, vaccines, and diagnostics for biodefense and emerging infectious diseases.

New NOSI Prioritizes Malaria Vaccine and Monoclonal Antibody Discovery

Help ensure future effective global malaria control and elimination by focusing on “combination” vaccine concepts to improve efficacy, targeting one or more parasite antigens of the different life cycle stages of the parasites.

Act Now for Funding to Establish T32 Training Slots for Data Science

Predoctoral trainees should become capable of applying data science methods and technologies across infectious and immune-mediated diseases research domains.

Contribute to Rare Diseases Clinical Research Consortia

Each consortium will advance and improve diagnosis, management, and treatment of numerous, diverse rare diseases through highly collaborative, multi-site, patient-centric, translational, and clinical research.

Develop Diagnostics, Therapeutics, and Vaccines for Herpes Simplex Virus

Apply if you can further the development of new products to prevent herpes simplex virus infection and improve the diagnosis and treatment of patients living with herpes.

Propose a Multiproject Cell and Gene Therapy Research Program for HIV Cure

NIAID will support integrated multi-project research programs applying emerging and improved technologies to develop innovative gene- or cell-based HIV cure approaches.

Funding to Evaluate Novel Diagnostics for Tuberculosis in Endemic Countries

Propose a partnership of investigators and existing clinical study sites in tuberculosis (TB) endemic countries, to evaluate early-stage TB diagnostic tests, assays, and strategies.

Find Funding for Ethical, Legal, and Social Implications Research

NIH seeks research projects studying the ethical, legal, and social implications of human genetic or genomic research, including empirical qualitative and quantitative methods.

Support for Development of Promising MCMs for Radiation Injuries

Apply to conduct mid-stage research developing candidate medical countermeasures (MCMs) already demonstrating efficacy to mitigate or treat radiation injuries.

Funding Opportunity Focuses on Computational Models of Influenza Immunity

Propose a computational model that is data-driven, macromolecular, or hypothesis-based and mechanistically-driven and generalizable to multiple types of immune perturbations.

Administrative Supplement Supports Research on Radiation and Nuclear Medical Countermeasures and Biodosimetry Approaches

Receive funds to establish formal partnerships with other research groups to achieve outcomes that would likely be impossible without the expertise, models, and facilities available at partnering institutions.

Study Targeted Protein Degradation for Novel Anti-Infective Strategies

Plan to target mechanisms that are integral for the replication, growth, survival, or virulence of a pathogen, including toxins or toxin-related targets as novel anti-infectives.

Extended Deadline for Characterization of HIV Vaccine Formulations BAA

NIAID has extended the application deadline for the broad agency announcement (BAA) Rational Systematic Characterization and Selection of Adjuvants for HIV Vaccine Candidates; proposals are now due on July 7, 2023, at 4 p.m. Eastern Time.

Leverage Your Expertise Towards Genomic Centers for Infectious Disease Program

Help us develop and advance approaches in genomic technologies, computational tools, and large-scale data analysis of human pathogens and their interactions with the host and microbiome.

Still Time To Apply For Administrative Supplements on Women’s Health, Sex and Gender

Applications are due for three distinct initiatives providing administrative supplements for research at the nexus of women’s health, sex and gender, and health disparity populations.

Research Epidemiology of HIV Transmission in Mexico, Central and South America

Study the epidemiology of viral HIV suppression and determine study approaches or evidence-based digital treatment interventions to reduce HIV transmission in Mexico and South and Central America.

New Initiative Highlights Women’s Health Research Priorities

Apply to conduct research on disease and health conditions that predominantly affect women, present and progress differently in women, or are female-specific.

In The News

Clarification for Upcoming Fellowship Application Due Dates

If you are applying to a parent Fellowship notice of funding opportunity for the April 8 or May 7, 2025 Standard Due Dates, you must use the FORMS-H application forms and instructions. 

NIH Is Operating Under a Continuing Resolution

NIAID will remain funded at the level of fiscal year 2024 appropriations through March 14, 2025, when the current continuing resolution will expire.

New NIH Public Access Policy Lifts Embargo Period on Manuscripts

The new NIH policy mandates the submission of author-accepted manuscripts to NIH's PubMed Central without a 12-month embargo period.

December ACD Meeting—Defining Strategies for Major Initiatives Across NIH

NIH’s Advisory Committee to the Director (ACD) provides recommendations on program development, resource allocation, NIH administrative regulation, and other aspects of NIH policy.

Webinar Describes Changes Coming to Fellowship Application and Review

The newly structured candidate section will ask for four personal statements: 1) a statement of professional and fellowship goals, 2) a statement of fellowship qualifications, 3) a self-assessment, and 4) a statement of scientific perspective.

Replication as a Pathway to Reproducibility in Research

A new initiative will support efforts to independently replicate significant lines of research and validate novel technologies across different scientific research areas in preclinical, translational, and technology development studies.

Carrying Out a Data Management and Sharing Plan? Take Note of These Updates

Recipients of grants and cooperative agreements are now required to include in their Research Performance Progress Reports responses to several new questions that align with the Final NIH Policy for Data Management and Sharing. 

NIH Launches Grants & Funding Website Redesign

Last week, NIH completed a major overhaul of its Grants & Funding website. You can watch a video tour for a summary of key changes to the site’s organization and resources.

Reducing Administrative Burden: Redundant Just-in-Time Emails

As of October 1, 2024, NIH’s eRA system will no longer automatically generate and send just-in-time email notifications to applicants whose overall impact scores are below a designated level.

Provide Input on Postdoctoral Research Training and Career Progression

NIH seeks community feedback on several recommendations made by the Advisory Committee to the Director Working Group on Re-Envisioning NIH-Supported Postdoctoral Training.

Ease Educational Debt Through Loan Repayment Programs

To be eligible, you must be a doctoral-level clinician or researcher who’s committed to conducting NIH-qualified clinical research. If NIH approves your application, we will repay up to $50,000 each year toward your qualified educational debt.

Share Your Input on Draft Public Access Policy

The draft Public Access Policy builds upon NIH’s history of providing public access to scholarly publications resulting from the research it supports and proposes additional steps to accelerate access. 

June’s ACD Meeting—Outlining Plans to Pursue Major Priorities

NIH’s Advisory Committee to the Director (ACD) provides recommendations on program development, resource allocation, NIH administrative regulation, and other aspects of NIH policy.

Revised Guidance for Reporting DMS Plan Activities in Progress Reports

When you complete your next Research Performance Progress Report, you may encounter new questions that address the NIH Data Management and Sharing (DMS) Policy.

Help Shape NIH-Wide Strategic Plan for Sexual and Gender Minority Health Research

Answer a request for information on topics that NIH should consider when developing the next NIH-wide Strategic Plan for Sexual and Gender Minority Health Research.

NIH Increases NRSA Stipend Levels, Shares Perspective

NIH announced Ruth L. Kirschstein National Research Service Award (NRSA) stipend levels for awards made on or after October 1, 2023, which saw their largest year-over-year increase since fiscal year 2017.

NIAID Adjusts Paylines, Restores Noncompeting Grant Funding Levels

NIAID now has an appropriation for fiscal year 2024, a key development as we determine how many awards the Institute can support in this fiscal year.

Consider a Conceptual Approach to the NIH Budget and Success Rates

The volume of awards that NIH is already obligated to fund each year can amplify, limit, or delay changes in success rates following a change in the overall budget.

Guidance for Videos Submitted as NIH Application Materials

To be accepted within an application, your video must demonstrate devices or experimental data with a temporal element, i.e., a need to show how something functions or occurs over time, or demonstrate movement or change.

A Note of Gratitude to 2023 NIAID Peer Review and Committee Volunteers

Join us in our annual appreciation of NIAID peer review and committee members, then learn how to volunteer for a peer review group yourself.

Share Feedback on NIAID’s Guiding Research Priorities and Themes

NIAID is now updating its Institute-wide Strategic Plan, and we invite feedback from the extramural research community on the research priorities and crosscutting themes that will drive our Strategic Plan.

For Foreign Regulatory Requirements, We Did the Research for You

Our online database serves as a central resource for country-specific clinical research requirements for regulatory and ethics approval, clinical trial lifecycle, sponsor responsibilities, informed consent, investigational products, and specimens.

December 2023 ACD Meeting—UNITE, RADx, and Postdoctoral Training

NIH’s Advisory Committee to the Director (ACD) members provide recommendations on program development, resource allocation, NIH administrative regulation, and other aspects of NIH policy.

Comment on NIH-Wide Strategic Plan for Autoimmune Disease Research

Establishing an NIH-wide strategic plan will help the new Office of Autoimmune Disease Research create opportunities for synergistic innovation and implement cross-cutting research.

Applicants—Before You Copy/Paste, Consider NIH’s Latest Case Study

Peer reviewers are prohibited from using and sharing materials from a confidential peer review meeting, and doing so constitutes a serious breach of confidentiality.

Update on Foreign Disclosure and Risk Management of Small Business Awards

NIH SEED has useful foreign risk case studies to demonstrate instances in which foreign involvement does or does not generate security risks.

Meet the Awarded Investigators of NIAID’s New Innovators Awards Program

Learn about those exceptional researchers whose projects are already funded through the NIAID New Innovators Awards program.

Guidance to Accompany Our Interim Financial Management Plan

NIAID has not reduced competing or noncompeting awards in some time, but we do so now in light of budget uncertainty.

An Acronym to Know—Plan for Enhancing Diverse Perspectives (PEDP)

In a Plan for Enhancing Diverse Perspectives, you'll broadly consider how diverse perspectives can advance research outcomes, in addition to bringing equity and inclusion to the science they inform.

Demonstrate Rigor When Communicating Research Outcomes

Science communication is rapidly evolving, and the growing use of preprints and the sheer number of published studies make it increasingly difficult to determine which findings are worthy of attention.

New Application Instructions for Data Management and Sharing Costs

The single “Data Management and Sharing Costs” line item will no longer be required; NIH recognizes that DMS costs may occur in multiple cost categories.

Reminder and Case Study on Harassment Reporting

NIH has expectations, policies, and requirements for recipient institutions to foster an environment free from harassment, including sexual harassment, discrimination, bullying, retaliation, and other forms of inappropriate conduct.

Share Your Input with OLAW—Streamlining IACUC Reviews and Guidance Disclaimer

Share input on a proposal to encourage use of designated member review (DMR), DMR subsequent to full committee review, veterinary verification and consultation, and administrative handling of increase in previously approved animal numbers.

Experience the NIH Campus Through a Dynamic, Interactive Virtual Tour

The virtual tour lets visitors from around the world learn about NIH’s mission, research, labs, and facilities by showcasing 20 in-depth tour stops on NIH’s campus. 

NIAID Wants Your Feedback on Strategic Plan to Accelerate Tuberculosis Research

Our revised Strategic Plan is structured around five strategic priorities that capitalize on recent advances in the field; each critical to the development and evaluation of knowledge and tools needed to end tuberculosis globally.

Prepare for October Policy Changes on Subawards, Foreign Subrecipients

The changes address the consortium relationship that a grant recipient needs to establish with an organization receiving a subaward under the grant to ensure compliance with NIH requirements.

Examine Public Feedback on Plan for Simplifying Review Criteria

NIH received more than 800 responses to a request for information on simplifying peer review criteria, a vast majority of which supported most of the proposed changes.

NIAID Posts Final FY 2023 Paylines for R01, R15 Grants

NIAID sets a separate R01 payline for new and early-stage principal investigators (PIs) to ensure success rate parity between established and new and early-stage PIs.

DEIA Prize Competition Offers $100,000 for Inclusive Excellence

NIH aims to recognize the transformative cultures, systems, projects, and processes developed by academic institutions to promote inclusive excellence and create environments that foster and value a culture of diversity, equity, inclusion, and accessibility (DEIA).

Seeking Input on NIAID’s DEIA Request for Information

What are the gaps and barriers to developing, diversifying, and sustaining a diverse extramural scientific workforce and building a scientific pipeline to support the NIAID mission?

NIAID Paylines and Budget Data Updates from March 2023

Use the Budget Data Comparisons table to compare the enacted funding levels for fiscal years 2022 and 2023 across multiple NIH institutes and centers, including NIAID. 

A Checklist to Recount Study Design for Vertebrate Animal Research

Heed NIH's call to improve complete reporting of results of vertebrate animal and cephalopod experiments by using the Animal Research: Reporting of In Vivo Experiments checklist.

Salary Cap and NRSA Stipend Levels Announced in Early 2023

Congress restricts the amount of direct salary paid to an individual under an HHS award. Effective January 1, 2023, the salary limitation is set at a rate of $212,100 for 100 percent effort.

Summary of January 2023 Advisory Council Meeting

NIAID Acting Director Dr. Hugh Auchincloss provided updates on HIV/AIDS, malaria, Ebola, a promising Marburg vaccine, universal flu vaccine efforts, non-viral asthma attacks, monoclonal antibodies to target Epstein-Barr virus, and human antibody response to vaccinations.

December’s ACD Meeting—Featuring Bill Gates and Dr. Anthony Fauci

NIH’s Advisory Committee to the Director (ACD) provides recommendations on program development, resource allocation, NIH administrative regulation, and other aspects of NIH policy.

Provide Input on Proposed Simplified Review Framework for NIH Research Project Grant Applications

The Revised Simplified Review Framework would reorganize five major regulatory criteria under three scored categories and reduce the number of non-score driving review considerations that reviewers evaluate.

Initial Interim R01 Paylines Posted for Fiscal Year 2023

We are starting fiscal year 2023 under a continuing resolution, which will run through December 16, 2022. Our budget officials are now calculating appropriate interim payline levels.

Paylines Page Updated for Research Project, Small Business Grants

Paylines—either percentiles (R01s only) or overall impact score order—are the funding cutoff points for investigator-initiated applications.

Summer Application Totals Give Clues to Pandemic Productivity

The extramural community collectively wrote and submitted a higher volume of research project grant applications amid pandemic shutdowns in summer 2020.

Recap of June’s Advisory Council Meeting

NIAID Director Dr. Anthony Fauci discussed topics like budget and legislation, and Dr. John Mascola, director of the Vaccine Research Center (VRC), described VRC's work on mRNA and therapeutic antibodies related to COVID-19 as well as on influenza vaccines.

Submit Collaborative Proposals for Infectious Disease and Immunology Research Awards

Submit a proposal centered on questions directly related to the Asia-Pacific region with potential to add to global knowledge about infectious diseases and immunology.

News Briefs and Worth Repeating

Unsure How to Link Your ORCID iD and eRA Commons Account? Watch This Video; New NIH Policy Ensures Patient Access to Certain Licensed Products; NIH Implements New Funding Opportunity Goals Text

News Briefs and Worth Repeating

NIH Releases Midcourse Review of the NIH-Wide Strategic Plan; New Resources Webpage for Researchers with Disabilities; Bookmark a Pair of NIH Informational Pages

Help Shape the NIH Strategic Plan for Disability Health Research

NIH invites feedback that will help shape the framework of the ensuing NIH Strategic Plan for Disability Health Research for Fiscal Years 2026 to 2030.

News Briefs and Worth Repeating

Increased Interim Paylines for Fellowship, Career Development Awards; NIH Develops Training Resources for Responsible Conduct of Research; Enhance Your Presentations with High-Quality Science and Biomedical Art Illustrations

Create an ORCID Account in Preparation for the May 2025 Common Forms for Biosketch Transition

Investigators will soon be required to use Science Experts Network Curriculum Vitae (SciENcv) to complete Common Forms and the NIH Biographical Sketch Supplement to produce digitally certified PDFs for their application submission.

News Briefs and Worth Repeating

Note an Addendum to NIAID’s Financial Management Plan for FY 2025; HHS ASPR Posts FAQs on DURC/PEPP Policy; New Scientific Integrity Policies Focus on Public Trust

News Briefs and Worth Repeating

Last Call to Answer the NIAID Funding News Survey; Register Now for Small Business Entrepreneurship Boot Camp; Double Dipping Could Lead to Payback; Instruction for Labs Working with Synthetic Nucleic Acids

Save Your Future Self Time and Effort by Exploring ClinRegs Today

To aid researchers planning such studies around the globe, NIAID maintains the ClinRegs database of country-specific, clinical research regulatory information for 23 countries.

Register for NIH Training on Grant Compliance Processes, Policies, and Procedures

Join NIH policy experts for a webinar covering essential updates and ways in which the latest changes in NIH policies, systems, and resources might impact your institution’s grants administration procedures.

Clarification of Audit Requirements for Foreign Recipients and Subrecipients

Foreign organizations that expend $750,000 or more in federal awards during their fiscal year must conduct either a single audit, performed in accordance with the requirements outlined in 2 CFR 200 Subpart F, or a program-specific audit.

Changes to Biosketch, Other Support Form Submission Scheduled for May 2025

Beginning on May 25, 2025, NIH will require grant applicants and recipients to use Common Forms for Biographical Sketch and Current and Pending (Other) Support, rather than the NIH-specific format pages currently in use.

Explore NIH-Wide Data on New and Early-Stage Investigators

NIH and NIAID prioritize support for early-stage investigators as a strategy to sustainably strengthen a robust and diverse workforce.

A Window into Participant Inclusion in Clinical Research

A central goal of NIH policies is to ensure that the demographics of participants in our clinical research will inform clinical practice to benefit people who are affected by the disease or condition under study.

Provide Input for RFI on Public Engagement in NIH-Supported Clinical Research

Through a new request for information (RFI), NIH seeks input about engaging the public throughout all stages of clinical research; not solely during recruitment or participation in clinical research and trials.

Proposed Policy to Promote Patient Access to Products Based on NIH-Owned Inventions

Provide feedback on a draft policy and accompanying draft license agreement language that incorporates patient access in the commercialization process for NIH-owned inventions.

Send Feedback on Proposed Terminology for Clinical Research

FDA and NIH are requesting comments regarding the clinical research terms related to innovative clinical study designs, including studies using real-world data to generate real-world evidence.

NIAID Adjusts Requirements for Some Career Development, Training Awards

We announced a medley of changes for our career development and institutional training awards meant to help us better foster future investigators and maintain a balanced research training portfolio.

Sample Grant Applications Serve as Exemplary Guides

NIAID shares sample applications to provide examples of good grantsmanship and successful approaches to presenting a Research Strategy and Specific Aims. 

News Briefs and Worth Repeating

Parent R01, R03, R21 NOFOs Will Now Expire in January 2025; Consider a New Perspective on Writing with Narrative Structure for Grant Applications; Remember May 27 Deadline for Input on NIAID’s Next Strategic Plan

Check Out Annual Update on Cumulative Investigator Rate

The Cumulative Investigator Rate is an NIH-wide person-based metric, calculated as the number of unique principal investigators (PIs) who were designated on a research project grant (RPG) award, divided by the number of unique PIs who were designated on an RPG application over a 5-year period.

NIAID’s Tuberculosis Data Repository Promotes Open Access

NIAID’s TB Portals Program is a global collaboration of clinicians, researchers, and data scientists united in the mission to eradicate tuberculosis.

Reflecting on NIH Efforts to Provide Support for Childcare Costs

Each National Research Service Award fellow or trainee is eligible to receive $2,500 per budget period toward expenses for childcare provided by a licensed childcare provider.

Avoid Unilateral Closeout on Your Grant by Submitting Timely Closeout Reports

If a recipient does not submit all required closeout reports within a year of the period of performance end date, NIH must unilaterally close the grant and report the recipient's failure to comply with the terms and conditions of award.

Before You Apply, Find Instruction on NIH’s DMS Policy

NIH's Data Management and Sharing (DMS) Policy requires sharing of all scientific data, defined as all data necessary to replicate research findings regardless of whether the data are used to support scientific papers.

Consider Collaborating in U.S.-Finland Biomedical and Behavioral Research

U.S. institutions can submit investigator-initiated grant applications and, if selected for funding, the Research Council of Finland may fully fund the Finnish investigators.

News Briefs and Worth Repeating

Subawards Policy Changes Take Effect on January 1, 2024; NIH Is Currently Operating Under a Continuing Resolution; Podcast Episodes Discuss the Hidden Curriculum for Early-Career Researchers

News Briefs and Worth Repeating

Dr. Monica Bertagnolli Is the New NIH Director; Attend Webinar for DEIA Excellence Supplemental Awards; Prepare Now for Upcoming Opportunity on Systems Modeling; Register for Native American Health Research Webinar on January 25; Monthly Automated Reminders for Rejected Final FFRs

An Update on Improving NRSA Fellowship Review

A trans-NIH committee will develop a timeline and implement changes to improve review of Ruth L. Kirschstein National Research Service Award (NRSA) individual fellowship applications.

Share Your Perspective on NIH’s Plan to Safeguard Scientific Integrity

The draft NIH Scientific Integrity Policy establishes the appointments of, and roles and responsibilities for, the positions of NIH Chief Scientist and Scientific Integrity Official.

News Briefs and Worth Repeating

Join NIH Webinar on Subaward Rules and Procedures; Eligibility Window for F30 Applicants Is 48 Months from Matriculation; Attend NIAID Workshop on Approaches to Bacteria Antigen Discovery; Answer a Pair of RFIs from NIH’s Office of Data Science Strategy; Change to Organization Eligibility for STRONG Funding Opportunity

Leverage the New NIAID Data Ecosystem Discovery Portal

You can use our new tool to search across millions of public datasets to find infectious and immune-mediated disease data for reuse and reanalysis.

Attend September 12 Webinar for Postdoctoral Researchers from Diverse Backgrounds

The Maximizing Opportunities for Scientific and Academic Independent Careers program supports researchers from diverse backgrounds through individual postdoctoral career transition awards and institutionally-focused research education cooperative agreements.

Check out Grantsmanship Guidance from NIGMS

For help while you draft your application, consider recruiting colleagues from your institution and other scientific peers to volunteer to provide feedback on your application.

NIH Reviewers—Come Next May, Required Review Integrity and Bias Awareness Trainings

Survey results show that over 90 percent of reviewers reported the training modules were effective and they felt better prepared to take action afterwards.

August 10 Is a Key Date for NIH Review Group and Committee Members

NIH’s Continuous Submission Policy allows appointed members of review and advisory groups to submit applications to certain notices of funding opportunities after the standard deadline.

June’s ACD Meeting—Updates on Broad Challenges Facing NIH

NIH’s Advisory Committee to the Director (ACD) held its most recent meeting on June 8 and 9, 2023. ACD members provide recommendations on program development, resource allocation, NIH administrative regulation, and other aspects of NIH policy.

Share Your Innovative Ideas for Bold Research Initiatives with NIH Common Fund

NIH requests ideas for biomedical and behavioral research challenges and opportunities that may be of interest to the Common Fund for future investment.

Provide Feedback to Improve Fellowship Application Review Criteria

NIH tasks peer reviewers with identifying the most promising trainees as well as excellent, individualized training programs that will help them become outstanding scientists.

Lasker Program—Join NIH as a Clinical Researcher

NIH will employ and support up to five exceptional early-stage investigators who have not yet achieved tenure at a research institution.

Coming June 2023—Modernized ClinicalTrials.gov Website

The National Library of Medicine based ClinicalTrials.gov modernization efforts on user feedback to improve how visitors search, view, and download information about clinical trials.

A Rule Change for Preliminary Data as Post-Submission Materials

NIH will allow applicants to submit preliminary data as post-submission materials for new applications (Type 1) if the notice of funding opportunity uses the R01, R03, or R21 activity codes and allows preliminary data.

Understand the Peer Review Process to Inform Your Next Application

You may be able to anticipate which standing review group and primary reviewers are most likely to review your application, then write to fit your reviewers' areas of scientific focus and levels of understanding.

Provide Feedback to Help NIH Evaluate Postdoctoral Research Training

Share your thoughts on the roles and responsibilities of academic postdocs, including challenges in recruitment, retention, and quality of life of postdoctoral trainees.

Contribute to NIAID’s Efforts on Diversity, Equity, Inclusion, and Accessibility (DEIA)

NIAID invites information and recommendations to enhance DEIA across the Institute’s funded activities, such as strategies to address any systematic and structural barriers to receiving NIAID research funding that may exist.

NIAID Updates Interim R01, R03, and R21 Paylines

NIAID uses paylines as funding cutoff points for certain types of investigator-initiated grant applications. Last week, NIAID updated the interim paylines for research projects (R01), small grants (R03), and exploratory/developmental grants (R21).

NIH Announces Revisions to NIH Grants Policy Statement for Fiscal Year 2023

The NIH Grants Policy Statement provides up-to-date policy instruction that serves as the standard terms and conditions of award for NIH grants, as well as guidance for applicants pursuing an NIH grant.

News Briefs and Worth Repeating

Use New Versions of Parent Announcements; Comment on Use of Metadata to Increase Transparency of Research Results; Updated eRA Resource Aligns Training Tables with New FORMS-I Requirements; Stream NIAID's Advisory Council Meeting on January 27.

News Briefs and Worth Repeating

HHS Policy Also Caps Indirect Salaries Paid Using Award Funds; Small Business Recipients—Get Help to Hone Your Product Pitch; Read Summary of Recent Artificial Intelligence Use Cases at NIH

News Briefs and Worth Repeating

With Gratitude to Dr. Hugh Auchincloss, and a Welcome to Dr. Sarah Read; Newcomer to NIH Funding? Attend the NIH Grants Process Primer Webinar; OLAW Annual Reports Are Due on December 1; Loan Repayment Program Application Deadline Is November 21

News Briefs and Worth Repeating

Reminder of NIH Policy on Late Applications Caused by Weather Emergencies; Examine Data on Professional Degree Types in NIH’s Grant Portfolio; NIH Revises Its Definition of Sexual and Gender Minority Populations

News Briefs and Worth Repeating

A Reminder for Authorized Organization Representatives to Verify Grant Assignments; NIAID Continues Participation in Ecology and Evolution of Infectious Diseases Program; Refresh Your Knowledge of NIAID and NIH Data Sharing Policies; Award Challenge Offers Prizes for Data Reuse Projects

News Briefs and Worth Repeating

Attend NIH Webinars on Grant Closeout, Fellowship Application and Review; Stay Sharp on Best Practices for Genomic Data Sharing; A Reminder for Small Businesses Seeking Funding in Women’s Health Research; Subscribe to New Quarterly Newsletter from COSWD for Funding Insights

News Briefs and Worth Repeating

Now Available: New Career Development Sample Applications; Hurry with Submissions for NIH Entrepreneurship Bootcamp; Distinguish the Priority Areas of NIH’s Institutes, Centers, and Offices

News Briefs and Worth Repeating

Change in Prior Approval Requirements for SBIR/STTR Recipients to Add a Subaward; Funding for Meetings to Support Data Harmonization of Autoimmune Disease Research

News Briefs and Worth Repeating

NIAID Strives to End the Use of Stigmatizing Language; Contract Vendors Can Submit Inclusion Data Directly into HSS; Nominate a Researcher for 2024 SGM Research Awards Program

News Briefs and Worth Repeating

Temporary Exemption of H5 Avian Influenza Viruses from Select Agents Regulations; NIH Sets Expectations for Upholding the NIH-Lacks Family Agreement; Answer Request for Information on All of Us Research Program Data

News Briefs and Worth Repeating

New Government-Wide Policy for Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential in May 2025; NIAID Sets Final R01, R03, and R21 Paylines for FY 2024; NIH Increases Childcare Support for NRSA Fellows and Trainees

RFI Seeks Input on NIAID Immunology Knowledge Management

Share feedback on existing immunology resources, future needs of the research community, and potential future directions of data and knowledge management.

NIAID’s Commitment to Early-Stage Investigators in HIV Research

Senior investigators should concern themselves with the career trajectory of promising HIV researchers, and at NIAID we are exploring ways to maximize our resources to fund as many worthy candidates as possible.

News Briefs and Worth Repeating

Register for April 17 Webinar on Simplified Review Criteria; NIAID Receives an Appropriation for Fiscal Year 2024; NIH’s Office of Laboratory Animal Welfare Suggests Flexibilities

New Request for Information on Uniform Common Data Elements

NIH invites community feedback on upcoming efforts to develop and implement a set of minimum core common data elements for NIH-funded clinical research and trials.

Provide Feedback on NIH Strategic Plan for HIV and HIV-Related Research

NIH’s Office of AIDS Research will use its next Strategic Plan as a basis for developing the NIH HIV research budget, outlining HIV research priorities, and conveying information about NIH HIV research priorities to the scientific community.

Moderate Increase in Salary Cap for NIH Grants

The direct salary for individuals under NIH grant and cooperative agreement awards cannot exceed “Executive Level II” of the Federal Executive pay scale. Effective January 1, 2024, the salary limitation for Executive Level II is $221,900.

News Briefs and Worth Repeating

NIAID Is Operating Under a Continuing Resolution; Bookmark Helpful NIH SEED Resources for Small Businesses; Prepare Now for Opportunity on Cell and Gene Therapies for HIV Cure; Watch Webinar to Hone Applications for DEIA Supplements

Early-Stage Investigators Can Get Support for Innovative Pivots

The initiative is designed for early-stage investigators who want to initiate a research project in an area different from their previous research focus or training experience, and therefore have not produced preliminary data.

News Briefs and Worth Repeating

Prepare for Opportunity to Advance MCM Development for AMR Bacteria and Fungi; Submit Annual Reports to OLAW by December 1, 2023; Provide Feedback on HIV and Women’s Health, Consent Language for Digital Technologies.

NIAID Recognizes and Supports At-Risk Investigators

An at-risk investigator has had substantial, independent NIH funding as a principal investigator and, unless successful in securing a substantial research grant award in the current fiscal year, will have no substantial research grant funding in the following fiscal year.

Listen to NIH Podcast on Reporting Your Scientific Progress

Be sure your Research Performance Progress Report encapsulates the most recent project period with a fresh summary. If your report text seems identical to last year, your program officer will worry there's been a lack of progress.

News Briefs and Worth Repeating

Stream Our Advisory Council Meeting on September 11 with NIH Videocast; Answer RFI on Dual Use Research of Concern and Potential Pandemic Pathogens Oversight; Provide Feedback on a Meaningful Adjustment to NIH’s Mission Statement; Help NIH Address Safety for Recombinant or Synthetic Nucleic Acid Molecules

Distribution of Applications by Career Stage Held Steady Through the Pandemic

The most recent analysis found a continual increase in the proportion of applications designating either female or underrepresented minority early-stage investigators both before and after the pandemic.

Answer Call for Feedback on Novel Alternative Methods

In which areas of biomedical research could novel alternative methods provide investigators with new means to answer key research questions in ways that cannot be accomplished currently through traditional methods like animal models?

Human Subjects System—Quick Guide for Warnings and Errors

A new resource from eRA describes red flags that users commonly encounter when using the Human Subjects System to report, view, and update a project’s human subjects enrollment, inclusion, and clinical trial data.

Check Out Resources on Sex as a Biological Variable

NIH’s Office of Research on Women’s Health offers training modules, videos, and other tools to instruct biomedical researchers on properly accounting for sex as a biological variable.

Provide Input on NIH Herpes Simplex Virus Strategic Plan

Share feedback on NIH's Herpes Simplex Virus Strategic Plan and its prioirities for basic research, diagnosis, treatment, cure, and prevention by June 21, 2023.

Bookmark New Resource for Guidance Should You Need to Report a Concern

There are several types of concerns a researcher might need to report to NIH during the application process or while conducting NIH-supported research, from grant scams to research misconduct to peer-review integrity violations.

Citing Publications in Research Performance Progress Reports

Be careful not to over-cite publications, such as preprints, as well as training- and resource-type awards. If an award’s only contribution to a publication is non-personnel resources, do not list the paper.

Minimum Performance Standards, Tax Deductions for Small Business Awardees

Federal income/excess profits taxes are strictly not allowable charges to NIH awards, either as direct or facilities and administrative costs. However, the small business fee may be used to pay for a tax liability.

Inform NIH’s Strategy to Enhance Public Access to Research Results

NIH drafted a Public Access Plan that would alter the NIH Public Access Policy to reflect new priorities identified in a White House Office of Science and Technology Policy memorandum.

Prepare Your First Data Management and Sharing Plan

Start with NIH’s extensive guidance; a new page features sample data management and sharing plans and the frequently asked questions page explains how to account for data management and sharing in your budget.

NIH Shares Data on Investigators with Disabilities

To ensure a strong and diverse workforce and better understand workforce composition and participation in NIH programs, NIH regularly assesses the sex/gender, race, ethnicity,and disability status of its supported researchers.

Non-Discrimination Requirements in All New Grant Opportunities and Awards

HHS offers guidance on how to administer your program in compliance with applicable Civil Rights laws, e.g., sex discrimination and harassment, disability, and religious freedom.

News Briefs and Worth Repeating

Bookmark Updated Version of NIH Grants Policy Statement; Coming Soon: Reissued Parent NOFOs for Small Business Grant Applications; Review List of NIH Legislative Mandates for Fiscal Year 2024; Grants.gov Downtime Scheduled for this Weekend

News Briefs and Worth Repeating

Attend “NIH Grants Process: A Brief Walk-Through for Beginners” Event on May 15; Reminders for Small Business Concerns: TABA Supplements and Foreign Disclosures; Webinar to Discuss U54 Opportunity on Systems Modeling of Infection and Immunity

News Briefs and Worth Repeating

Attend Research Education Program Webinar on April 4, Apply by June 7; Public Access Policy Webpages Are on the Move; A Note on the Next NIH Grants Policy Statement Release

Attend Monthly Webinars to Hone Your Grant Writing Skills

NIAID is hosting a virtual grant writing webinar series called “Debuting Your Research Career: How to Plan for and Write Your First (or Next) NIH Grant Application.” This monthly webinar series is free and open to pre- and post-doctoral fellows, clinician-scientists, and early-career investigators.

News Briefs and Worth Repeating

Simplified Review Criteria Will Receive a Soft Launch; Provide Input on HIV Research Priorities Before March 28, 2024; Attend Virtual Seminar on Opportunities for Early-Career Researchers; NIH Has a YouTube Channel for Grants Policy Discussions

News Briefs and Worth Repeating

Tune in for NIAID Advisory Council Meeting on January 30, 2024; Attend NIH Office of Extramural Research Webinar on Grants Policy Changes; eRA Commons ID Required for Senior/Key Personnel, Other Significant Contributors; Offer Feedback on the NIH Strategic Plan for Data Science

News Briefs and Worth Repeating

I-Corps Deadlines and Dates for FY 2024 Cohorts Announced; Materials from CHIVIM Clinical Studies and Trials Available; Small Business Collaboration with Resource-Limited Institutions.

Share Your Views on Proposed Revisions to Biosafety Policy

Respond to a request for information on Potential Changes to the Policies for Oversight of Dual Use Research of Concern and the Potential Pandemic Pathogen Care and Oversight Policy Framework by October 16, 2023.

News Briefs and Worth Repeating

Dr. Jeanne Marrazzo Selected as NIAID’s Next Director; Collaborate with the AIDS Clinical Trials Group on HIV Remission and Cure; Stream Scientific Meeting on Congenital Cytomegalovirus Vaccine Research

Reference NIH Data on Cumulative Investigator Rates

The Cumulative Investigator Rate is calculated as the number of unique principal investigators (PIs) who were designated on an NIH research project grant divided by the number of unique PIs who were designated on applications over a 5-year period.

Don’t Miss Public Comment Period on Research Involving Children as Subjects

FDA and HHS’s Office for Human Research Protections published Draft Guidance to help stakeholders understand the processes used for review of research involving children as subjects that is not otherwise approvable by an IRB.

Yearly Tallies of the Postdoc Population—Data from NIH

NIH supports many postdocs and graduate students through the Ruth L. Kirschstein National Research Service Award Program, which includes fellowship (“F”) and training (“T”) awards.

News Briefs and Worth Repeating

Attend Seminar on How Diversity Impacts Innovation in Team Science; New Visual Appearance Planned for Popular eRA Modules

News Briefs and Worth Repeating

NIH Natural Disaster Policy Applies to Recent Weather Events; Confirm Accuracy of Grants Information for Fiscal Year 2023; Share Feedback on Proposed Guidelines for Cephalopod Care and Use

Speak Up on Proposed Revisions to the NIH Public Access Policy

NIH is considering revisions to the Public Access Policy following calls from the White House to enhance public access to the results of federally funded research. NIH’s Office of Science Policy will host a listening session on April 12, 2023.

Register Now for Two-Day Immunosenescence Workshop in May

NIAID is cohosting an Advances in Aging, Immunity, and Chronic Inflammatory Diseases workshop on May 9 and 10, 2023. The workshop will be hybrid, meaning there are options to attend in person or virtually.

Update to Funding Opportunity for COVID-19 Personal Protective Equipment

A note for those conducting or planning COVID-19-related vaccine or treatment clinical trials and clinical studies supported by NIAID’s fiscal year 2020 emergency pandemic appropriations.

Advice Corner

Ways to Link Up for Collaborative Research

Whether cultivating partnerships across fields and institutions resonates with your research goals, or you decide to pursue a notice of funding opportunity that requires collaborators, we suggest several resources to develop those pursuits.

Consider These Points When Collecting Letters of Support

The letters of support should reflect the roles and commitment of collaborators on the project as well as the rate and price for contracted services, while also aligning with your application’s research strategy and budget.

Want to Master NIH Funding? Tune In to These Grants Podcasts

Learn how to better navigate the NIH grants application and award process.

Unobligated Funds, Renewals, and Carryovers—Oh My!

Submitting complete and timely Federal Financial Reports is an important step to ensure NIAID’s prompt review and consideration of any carryover requests.

How to Determine Where Your Application Will Be Reviewed

If you know your application will go to a Center for Scientific Review study section, you can request assignment to the most appropriate one.

Small Business Applicants—Know Your Actual Budget Cap

The Small Business Administration (SBA) sets caps for total costs on small business grant awards for all federal agencies, above which an agency must request SBA approval.

Take Some Hints from Our New R01, K08 Sample Applications

NIAID recently posted two R01 sample applications and one K08 sample application to serve as examples of outstanding grantsmanship and demonstrate a successful approach to presenting a research plan.

Don’t Get Spooked—Check the Grant Number for Unfunded Notifications

If you or your institution receives a notification alerting you that a change was made to your application status, pay attention to the grant application number referenced in the message.

Quiz Yourself on NIH Acquisitions Terminology

How familiar are you with NIAID’s solicitation and contract vocabulary? Test your knowledge by taking our quiz and pay attention to the explanations for each answer.

How NIH Responds to Allegations of Foreign Interference

NIH requires disclosure of other support, foreign components, and conflicts of interest so that staff can ensure funded projects do not receive duplicative support, research is conducted objectively, and sensitive data are kept confidential.

Double Check “Related Notices” Section of Guide Notices for Key Updates

When NIH issues a correction or update to an NIH Guide notice, the original notice’s text may not change since NIH can correct some fields in the original notice but not others.

What’s NIH’s Policy on Sharing Model Organisms?

Investigators must include plans for sharing unique model organisms and related resources in their grant applications or contract proposals. Investigators unable to share model organisms or resources are required to state why sharing is not feasible.

R01 Renewal Applications: Calculate Your Budget Cap

NIAID caps R01 research project grant renewals at 20 percent above the direct costs of the last competing award period, less the costs of certain items like subawards’ facilities and adminsitrative costs.

Contacting a Grants Management Specialist—For What and How?

As an applicant or a funded investigator, there's a good chance you'll need guidance on administrative or budget matters related to your grant or cooperative agreement.

For Ancillary Studies, Consider NIH Definitions Carefully

An ancillary study is an independent research project that uses samples or data from a parent study to extend knowledge in scientific areas beyond the original scope of the parent study. It may qualify as a clinical study or a clinical trial.

Where to Check in an Opportunity for the Earliest Start Date

Most notices of funding opportunities list the application due date, peer review date, Advisory Council round, and earliest project start date in the “Key Dates” section of Part 1. Overview Information.

Application Viewing Window Isn’t a Due Date Loophole

If you identify a mistake or a missing form while examining your application in the viewing window, then your signing official should reject the application so that you can correct the error and submit a replacement application.

Addressing Common Misconceptions About NOSIs

NIH uses notices of special interest (NOSIs) to invite applications on high-priority and high-opportunity areas of science. NOSIs are designed to reduce administrative burden on NIH staff and grant applicants alike.

Acknowledge NIH Support Appropriately in Research Products

NIH staff use award citations to evaluate the impact of grant funding on scientific progress over time. Similarly, peer reviewers rely on award citations to help assess award productivity.

Competing Revisions and How They Differ from Administrative Supplements

A competing revision provides additional funding for activities that call for an expansion of your original scope of award, whereas administrative supplements fund activities that, while unforeseen when the application was being submitted, are still within the scope of the project.

Instrumentation Program NOFOs Could Be Instrumental to Your Research

NIH’s Office of Research Infrastructure Programs supports purchases of state-of-the-art, commercially available instruments on shared-use basis to enable or enhance conduct of cutting-edge research by NIH-funded investigators.

How to Approach Application Resubmission Strategy

Try to incorporate new preliminary data, literature citations, letters of reference, and any other relevant updates that came about in the months between submissions.

Understand Clinical Trials to Choose the Right Funding Opportunity

NIH defines a clinical trial as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.

Know What Application and Progress Report Information NIH May Share

Any recipient of federal support and the information they submit to the government is subject to the Freedom of Information Act (FOIA).

For Prior Approval Requests, “Other” Does Not Mean Everything Else

Within eRA’s Prior Approval Module, a variety of templates exist to facilitate the most common request types: carryover, change of investigator, no-cost extension, big grants, and withdrawal.

Distinguish Between Delayed Start and Delayed Onset in Human Subjects Research

If you are planning a delayed start to a human subjects study but wrongly mark it as a delayed onset study, your application will be missing important details which may negatively affect your score.

Before a Collaboration Goes Awry, Have a Plan in Place

Even successful partnerships experience disagreements and disputes. To ensure those moments don’t derail your science, you need to have an established conflict resolution plan.

Find the Right Person to Help You with General Inquiries

Whom should you ask for help with general matters like identifying an appropriate funding opportunity or discovering available resources?

Does Your NIAID Grant Opportunity Have Questions and Answers?

Any time you read an NIAID notice of funding opportunity, build a habit of checking whether there is an associated questions and answers page.

Don’t Overlook the Three Types of Overlap

Overlap may be scientific, budgetary, or commitment related. To resolve concerns around overlap, you’ll need to provide information as part of the Just-in-Time (JIT) process that occurs after peer review, when NIAID is considering the application for funding.

Caveats to Consider Before Preaward Spending

You may ask your institutional business office for preaward spending approval to cover costs up to 90 days before the start date of the initial budget period of a new or renewal award.

Include Participants’ Ages When You Input Data in the Human Subjects System

The NIH inclusion policy ensures that children must be included in all NIH-conducted human subjects research unless there are scientific or ethical reasons for exclusion.

Early-Career Researchers—Propose a Budget that Meets Your Research Needs

Request a budget sufficient to make your proposed project successful. Do not risk peer reviewers judging your costs insufficient to the work or deeming you naive to the price of conducting successful research.

Would a Career Development Award Help You?

Our career development award programs support postdoctoral scholars and scientists at early- and mid-career stages, including those from diverse backgrounds or returning to biomedical careers.

Loan Repayment Programs Can Offset Your Educational Debt

To be eligible, you must be a doctoral-level clinician or researcher who is committed to conducting NIH-relevant research at a domestic, non-profit, or government organization.

Publicize Your Research Findings Through NIAID

When you’re ready to publicize your scientific discoveries, let NIAID help spread the word. Through a variety of communication vehicles, our News and Science Writing Branch highlights the work of NIAID-funded researchers.

Find Your Career Calling at NIAID

While many NIAID careers require expertise specific to our area of science, other positions don’t require an advanced or scientific degree. 

Liquidation—Money Matters for When Your Time Is Up

NIH grant recipients have 120 days from the end of a performance period to liquidate obligations by drawing funds from the Payment Management System.

Caution—Roles Determine Eligibility and Other Requirements

We cover role-related terms that have caused confusion like co-investigator, collaborator, consultant, other significant contributor, and staff scientist.

International Awards—Part III. Build Collaborations

Collaborators may use different types of agreements to facilitate partnerships, including research collaboration agreements, material transfer agreements, and data transfer agreements.

Having Technical Difficulties? Here’s How to Meet the Submission Deadline

Know how to respond if you get the error message “Data Management and Sharing Costs can only be entered on one of the lines in Section F Other Direct Costs within the same budget period."

Don’t Leave Your Mentorships to Chance—Tips for Inviting Support

In practice, most mentees need a developmental mentoring network that consists of multiple social relationships each fostering career development and personal growth.

International Awards—Part II. Foreign Projects

Foreign applications need to propose talent, resources, populations, or environmental conditions not in the United States, e.g., access to a unique study population.

Before You Get Carried Away Planning a No-Cost Extension

In order to spend unobligated funds from an earlier budget period during a no-cost extension, absent automatic carryover authority, you first need to confirm NIAID’s prior approval of a carryover.

International Awards—Part I. Determining Eligibility

The eligibility of a principal investigator differs from that of an institution. This is important in the context of fellowships and career development awards, where non-citizens may be working at U.S. institutions, or U.S. citizens may be working at international institutions.

Seek NIAID’s Help for an Investigator-Initiated Clinical Trial Application

NIAID strongly encourages consultations to apprise principal investigators of the time, cost, and regulatory obligations that come with seeking and receiving an investigator-initiated clinical trial award.

Remember to Address Rigor and Reproducibility in Your Next Application

NIH expects researchers to use unbiased and well-controlled experimental design, methodology, analysis, interpretation, and reporting of results.

G11 Sample Applications and Opportunity for Foreign Grant Administrators

Three new high-scoring, successful G11 samples reflect excellent grantsmanship and serve as educational resources for other applicants and award administrators.

Send Applications Early To Avoid Electronic Submission Errors

NIAID cannot correct an error spotted in your application after the receipt deadline on your behalf, even if an overlooked content error would render your application nonresponsive to an initiative's requirements.

CDC/NIH Resource Gives Guidance on Biosafety Best Practices

Biosafety in Microbiological and Biomedical Laboratories is an advisory document recommending best practices for safely conducting work in biomedical and clinical laboratories from a biosafety perspective.

Reader Questions

“What is the salary cap for a research project grant or cooperative agreement?”

“Will NIH share my grant application’s abstract publicly?”

“Why isn’t a single program officer overseeing all my grants?”

“What is an investigational new drug and an investigational device exemption?”

“Does the Big Grants policy check for an application’s average annual direct costs or any single year above the threshold?”

“Can my program officer help to resolve a dispute with my grant’s subrecipient?”

“I’d like to apply for an R21, but I think I’ll need a bigger budget and longer project period. What should I do?”

“Am I more likely to receive a grant if my application’s budget request is thrifty?”

“Can I change my active R01 award from a single PI to a multiple PI award?”

“What is a limited competition? When does NIH choose to limit competition?”

“What determines whether separate AIDS due dates apply to an application? For example, would a fellowship application with an AIDS-related project qualify?”

“How can I follow the NIAID Advisory Council meetings on September 9, 2024?”

“What is a PAR?”

“Do subrecipients need to submit progress reports to NIAID?”

“Are CDC and FDA part of NIH?”

“I saw the NIAID Research Agenda for 2024 H5N1 Influenza and I want to apply for H5N1 research funding, but I can’t find a corresponding notice of funding opportunity. What should I do?”

“What is a Specific Aim?”

“If I receive funding as part of a multiple-PI application, do I lose my new PI status?”

“For a training (T) award, does NIH set a salary cap?”

“May I request that my grant award be assigned to a particular program officer?”

“Where should I list references used to justify key aspects of my research plan?”

“How long do I have to prepare and send a resubmission application?”

“Does the Public Access Policy cover articles written by trainees supported by an institutional training award?”

“Is my National Research Service Award individual fellowship stipend considered taxable salary?”

“When will I know the study section to which my application was assigned?”

“Is SARS-CoV-2 considered a select agent?”

“If I submit two distinct R01 applications, and my percent effort on each exceeds 50 percent, what happens?”

“My organization is a foreign grant recipient. When arranging a subaward with another organization in my country, should I consider that subaward to be foreign or domestic?”

“Will the new peer review criteria impact applications due on or after January 25, 2024?”

“What is the average age of a first-time principal investigator?”

“If I applied well ahead of the due date, and I want to change an aspect of my application, can I withdraw it and submit again?”

“What should my biosketch look like if I am a predoctoral candidate applying for an F30?”

“Where can I find the Foreign Disclosures form for small business concerns?”

“The next standard due date for AIDS and AIDS-related applications is September 7, 2023. When is my AIDS-related R01 resubmission application due?”

“Are sexual and gender minority populations included within the Notice of NIH’s Interest in Diversity?”

“Does NIAID allocate set-aside funds for notices of special interest?”

“Has NIH set any restrictions on the use of artificial intelligence platforms?”

“What are NIAID’s R03 and R21 paylines for fiscal year 2023?”

“What is the difference between the AREA and REAP research enhancement awards?”

“My withdrawn resubmission application is still listed in the eRA Commons. Can I submit an updated version of the same application?”

“Can I avoid the budget cap for renewal applications by submitting a new application instead?”

“Does the big grants policy apply to all NOFOs and NOSIs?”

“Have NIAID’s extramural research priorities changed since Dr. Fauci’s retirement?”

“I applied for a research grant using the FORMS-G application form set. I am now preparing a resubmission application. Which form set should I use?”

“What is a NOFO? How do NOFOs relate to FOAs and NOSIs?”

“What does basic research mean?”

“Should I be using the FORMS-H application form set now?”

“Will my resubmission be assigned to the same peer reviewers as my initial application?”

“Can an international company apply for a small business award?”

“Are there guidelines for the font I use in my application?”

“If I include an illustration in my application, does it count against my page limit?”

“One of my key personnel listed several preprints in their biosketch. Is that acceptable?”

“Can I submit the same research project as an R01 application and an R21 application simultaneously?”

“Does NIAID monitor the visa status of foreign investigators at domestic institutions?”

“How many extramural scientists participate in NIH’s peer review process?”

“Does NIAID use the R35 activity code?”

“I received an R56-Bridge award. What type should my next R01 application be?”

“Can I place hyperlinks in my application’s Research Strategy section to provide context?”

“For a Small Business Innovation Research (SBIR) Phase IIB grant application, must my existing Phase II award be a grant, or would a Phase II contract award also suffice?”

“For a resubmission application, if I previously received NIAID’s agreement to accept assignment of a big grant for the original application, can I use the same acceptance letter?”

“Are consultants considered senior/key personnel?”

“Are there parent notices of funding opportunity for cooperative agreements?”

“When is the next NIH Advisory Committee to the Director meeting?”

“Can I attend the open portion of NIAID’s May Council meeting in person?”

“There are two active versions of Mentored Patient-Oriented Research Career Development Award (Parent K23, Independent Clinical Trial Not Allowed). Which should I use for the May 7, 2024 due date for AIDS-related applications?”

“Can I apply for an R01 grant with a 2- or 3-year project period?”

“What organizations qualify as small businesses?”

“The funding opportunity through which I'd like to apply has its next due date on a Saturday. When is my application actually due?”

“Do program officers attend peer review meetings?”

“Has the Supreme Court’s ruling on affirmative action in college admissions changed NIH’s funding approach and priorities?”

“Can a non-U.S. citizen receive a K99/R00 award?”

“Does NIAID establish my organization’s F&A costs rate?”

“What are NIAID’s expectations for a principal investigator approaching retirement?”

“When is the next NIH Advisory Committee to the Director meeting?”

“What is a competitive revision?”

“Are people with disabilities designated as a population with health disparities for research supported by NIH?”

“Does NIAID have a shared instrumentation grant (S10) notice of funding opportunity available?”

“Is there a tutorial for using NIH RePORTER?”

“Can principal investigators (PIs) on a multiple PI application work at different institutions?”

“Will the Supreme Court’s ruling on affirmative action in college admissions impact NIH’s funding approach and priorities?”

“Does NIH offer web trainings on human research protections?”

“Should I summarize my research project in the application’s cover letter?”

“Can I apply for a conference award to attend a scientific meeting?”

“Who writes the summary statement following my application’s peer review?”

“Can I find extramural contract information on NIH RePORTER?”

“Does NIAID set a limit for how much total funding support an investigator can receive across all grant awards?”

“Is there a way to tell if or when an expired notice of funding opportunity is likely to be reissued?”

“What is a prize competition? Is it a type of grant or contract?”

“Can a notice of funding opportunity (NOFO) change its requirements after publication?”

“Is the public health emergency exception to the Common Rule requirement for a single institutional review board for multisite research still in effect?”

“I saw NIAID’s DEIA request for information, but I think I answered one of those already?”

“Does NIAID include not discussed applications in the percentile calculation?”

“What demographic data does NIH collect on researchers via their eRA personal profile?”

“How can I follow the NIAID Advisory Council meetings on January 30, 2023?”

Contact Us

Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.

Stay Connected

Subscribe to Funding News email updates
@NIAIDNews

Genomics & Advanced Technologies Information for Researchers

Advanced technologies research fields, such as genomics, proteomics, and bioinformatics, hold great promise for developing new diagnostics, therapeutics, and vaccines to treat and prevent infectious and immune-mediated diseases.

Through the information offered here, researchers can learn about the science being conducted at NIAID and by NIAID-funded researchers. Researchers seeking funding can access opportunities to further their own research, while NIAID and NIH grantees can find out about available resources outside of specific funding opportunities. Recent publications, active networks, and ways to connect with other researchers are also available.

Connect With Other Researchers

Researchers at NIAID

 

Meetings

In  September 2018, NIAID convened a workshop to discuss opportunities to incorporate data-driven strategies in efforts to diagnose, treat, and prevent infectious diseases.

Read the Innovative Data-Driven Strategies for Infectious Diseases meeting report.

Antimicrobial (Drug) Resistance Information for Researchers

NIAID is funding and conducting research on many aspects of antimicrobial (drug) resistance, including basic research on how microbes develop resistance, development of new and faster diagnostics, and clinical trials designed to find new vaccines and treatments effective against drug-resistant microbes.

Through the information offered here, researchers can learn about the science being conducted at NIAID and by NIAID-funded researchers. Researchers seeking funding can access opportunities to further their own research, while NIAID and NIH grantees can find out about available resources outside of specific funding opportunities. Recent publications, active networks, and ways to connect with other researchers are also available.

Highlights

Scanning electron micrograph of Staphylococcus aureus bacteria.

Scanning electron micrograph of Staphylococcus aureus bacteria.

Credit
NIAID

NIAID Workshop Report: Systematic Approaches for ESKAPE Bacteria Antigen Discovery

On November 14 -15, 2023, NIAID organized a workshop "Systematic Approaches for ESKAPE Bacteria Antigen Discovery" to engage microbiologists, vaccinologists, immunologists, genomicists, and infectious disease physicians to explore novel technologies and to address and identify current roadblocks that impede advances in antigen and vaccine discoveries for the ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Enterobacter species).

Two female scientists looking though microscope

NIAID’S Antibiotic Resistance Research Framework: Current Status and Future Directions

This report describes NIAID’s portfolio of basic, translational, and clinical research in AR and outlines an updated array of innovative approaches based on the latest scientific advances and research opportunities to address this urgent public health priority.

NIAID’S Antibiotic Resistance Research Framework: Current Status and Future Directions

Support for Research

Funding

NIAID is always accepting researcher-initiated applications. Connect with NIAID program officers about potential funding for antimicrobial resistance research.

  • Dr. Erica Raterman, Preclinical Services Program Manager, Bacteriology and Mycology Branch, Division of Microbiology and Infectious Diseases
  • Dr. Erin Zeituni, Product Development Program Manager, Bacteriology and Mycology Branch, Division of Microbiology and Infectious Diseases

See a list of research initiatives focused exclusively or in part on antimicrobial resistance

See a full list of all current Funding Opportunities

Resources for Researchers

NIAID offers resources such as technologies available for licensing or collaboration, computer applications, and other tools and services to the general scientific community to advance basic, preclinical, and clinical research. See all resources for antimicrobial resistance researchers.

For researchers developing products such as diagnostics, vaccines, or drug therapies, check out NIAID's support for infectious disease product developers.

Connect With Other Researchers

Search for scientists at NIAID who research antimicrobial resistance in the scientist directory.

Search for scientists funded by NIAID who research antimicrobial resistance on RePORTER.

Programs and Networks

NIAID funds several programs and networks to advance research on antibiotic-resistant pathogens. 

Antibacterial Resistance Leadership Group (ARLG) 

The ARLG is a clinical network composed of scientific experts from government agencies, academic institutions, and nonprofit and industry groups around the world. The ARLG oversees a clinical research network that conducts studies on important aspects of antimicrobial resistance, including testing novel therapeutics and diagnostics.

Combating Antibiotic-Resistant Bacteria Interdisciplinary Units (CARBIRUs) 

The CARBIRUs are multidisciplinary research centers focused on bacterial pathogens for which antibiotic resistance poses a significant public health concern. 

Partnerships

An issue as complex as antimicrobial resistance requires a comprehensive approach that draws upon not only federal agencies and academic researchers, but also industry, healthcare providers, and individual citizens to advance basic and applied research as well as to support public health efforts.

Read more about some of our partners:

Follow Us on Social Media

@NIAIDNews on X
NIAID on LinkedIn
NIAID on Facebook
NIAID on Instagram

Employee Testimonial - Brian Epling, Infectious Diseases Fellow

NIAID Council Minutes September 12, 2022

The 202nd meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Monday, September 12, 2022. Dr. Anthony S. Fauci, Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair.

Vaccine Adjuvant Clinical Evaluation

Tuberculosis Research Advancement Centers (TRACs) Locations

Tuberculosis Research Advancement Centers (TRACs)

In 2022, NIAID established six new Tuberculosis Research Advancement Centers (TRACs) to foster multidisciplinary tuberculosis (TB) research and deliver exceptional mentorship to new investigators.

The newly established TRACs will provide scientific leadership and institutional infrastructure dedicated to TB research and will foster and enhance multidisciplinary collaboration. The Centers are dedicated to developing the next generation of scientific leaders in TB research through mentoring and training opportunities and by providing funding support for either new investigators pursuing TB research or researchers who want to enter the TB field at institutions within the TRAC network. The TRACs will provide shared research support for resources, services and training dedicated to TB, and will strengthen TB clinical research through international and/or domestic collaborations.

Main Area of Focus

The main goal of the TRACs is to provide administrative and shared research support to foster and elevate multidisciplinary TB research and provide exceptional mentorship to new investigators. TRACs will provide core facilities, services and mentoring opportunities to achieve the goals of the program.

Contact Information

Dr. Lakshmi Ramachandra
Section Chief
Tuberculosis and Other Mycobacterial Diseases Section
Respiratory Diseases Branch

Dr. Susana Mendez
Program Officer
Tuberculosis and Other Mycobacterial Diseases Section 
Respiratory Diseases Branch

Content Coordinator
Mason Booth
Cynthia Rojas
Content Manager
Mason Booth

Mentored Career Development Program for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed)

The purpose of this Notice of Funding Opportunity (NOFO) is to provide early-stage investigators with support and protected time (up to five years) for intensive, research-focused career development program activities under the guidance of an experienced mentorship team with expertise in both the preclinical application of nonhuman primate (NHP) models and in translation of the results from such studies to clinical application.

Subscribe to